{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T17:15:27Z","timestamp":1792084527514,"version":"4.4.0"},"reference-count":307,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,5,16]],"date-time":"2026-05-16T00:00:00Z","timestamp":1778889600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,5,18]],"date-time":"2026-05-18T00:00:00Z","timestamp":1779062400000},"content-version":"vor","delay-in-days":2,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100014584","name":"Universit\u00e4tsmedizin der Johannes Gutenberg-Universit\u00e4t Mainz","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100014584","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Fluids Barriers CNS"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>The blood-brain barrier (BBB) displays a highly organized and complex structure, which is important for maintaining brain homeostasis and protecting the brain from foreign molecules or pathogens. Receptor-mediated transcytosis (RMT) is one of the main delivery pathways across the BBB for molecules that cannot pass the barrier via, e.g. paracellular diffusion. For understanding the treatment options in neurodegenerative diseases such as Alzheimer\u00b4s disease (AD), it is important to investigate transport pathways and mechanisms at the BBB for a potential delivery of drugs, antibodies or other compounds across the BBB. This review provides an overview of the different transport variants across the BBB and how they can be targeted in order to promote internalization or secretion into or out of the brain. Therefore, we want to focus on two characterized proteins: the low-density lipoprotein receptor-related protein 1 (LRP1), which is a key mediator of amyloid \u03b2 (A\u03b2) clearance from the brain during AD, and transferrin receptor 1 (TfR1), which is already used as a target for antibody-delivery into the brain. Additionally, this review discusses two other important proteins, which have been less frequently addressed in research regarding transport mechanisms: P-glycoprotein (P-gp) as another transporter at the BBB and proprotein convertase subtilisin\/kexin type 9 (PCSK9), a well-known regulator of cholesterol homeostasis which promotes the degradation of the low-density lipoprotein receptor (LDLR) and LRP1. For these four main proteins, we aim to highlight existing approaches for targeting or inhibiting the aforementioned receptors or proteins. The approaches enable a higher penetration of the BBB, a better distribution in the brain, and ultimately fewer side effects of antibodies or nanoparticles. Here, we include lecanemab, trontinemab, dual TfR\/CD98hc shuttles, evolocumab and alirocumab, immunoliposomes and other nanoparticles targeting TfR1 or LRP1. We will further highlight approaches which differ from these common ideas and demonstrate the current state of the art regarding drug delivery and waste clearance across the BBB.<\/jats:p>","DOI":"10.1186\/s12987-026-00812-7","type":"journal-article","created":{"date-parts":[[2026,5,16]],"date-time":"2026-05-16T09:54:33Z","timestamp":1778925273000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Transport pathways across the blood-brain barrier for waste clearance and drug delivery"],"prefix":"10.1186","volume":"23","author":[{"given":"Lea S.","family":"Gr\u00f6bner","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claus U.","family":"Pietrzik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,5,16]]},"reference":[{"key":"812_CR1","doi-asserted-by":"publisher","first-page":"334","DOI":"10.3389\/fnins.2020.00334","volume":"14","author":"X Yu","year":"2020","unstructured":"Yu X, Ji C, Shao A. Neurovascular unit dysfunction and neurodegenerative disorders. Front. Neurosci. 2020;14:334. https:\/\/doi.org\/10.3389\/fnins.2020.00334.","journal-title":"Front. Neurosci"},{"issue":"11","key":"812_CR2","doi-asserted-by":"publisher","first-page":"1766","DOI":"10.1038\/sj.jcbfm.9600521","volume":"27","author":"IA Simpson","year":"2007","unstructured":"Simpson IA, Carruthers A, Vannucci SJ. Supply and demand in cerebral energy metabolism: the role of nutrient transporters. J Cereb Blood Flow Metab. 2007;27(11):1766\u201391. https:\/\/doi.org\/10.1038\/sj.jcbfm.9600521.","journal-title":"J Cereb Blood Flow Metab"},{"issue":"3","key":"812_CR3","doi-asserted-by":"publisher","first-page":"687","DOI":"10.1007\/s00441-014-1811-2","volume":"355","author":"B Engelhardt","year":"2014","unstructured":"Engelhardt B, Liebner S. Novel insights into the development and maintenance of the blood\u2013brain barrier. Cell Tissue Res. 2014;355(3):687\u201399. https:\/\/doi.org\/10.1007\/s00441-014-1811-2.","journal-title":"Cell Tissue Res"},{"issue":"9","key":"812_CR4","doi-asserted-by":"publisher","first-page":"1965","DOI":"10.3390\/ijms18091965","volume":"18","author":"Y Yamazaki","year":"2017","unstructured":"Yamazaki Y, Kanekiyo T. Blood-brain barrier dysfunction and the pathogenesis of Alzheimer\u2019s disease. IJMS. 2017;18(9):1965. https:\/\/doi.org\/10.3390\/ijms18091965.","journal-title":"IJMS"},{"issue":"4","key":"812_CR5","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1007\/s00281-009-0182-3","volume":"31","author":"M Bradl","year":"2009","unstructured":"Bradl M, Lassmann H. Progressive multiple sclerosis. Semin Immunopathol. 2009;31(4):455\u201365. https:\/\/doi.org\/10.1007\/s00281-009-0182-3.","journal-title":"Semin Immunopathol"},{"key":"812_CR6","doi-asserted-by":"publisher","unstructured":"Kurz C, Walker L, Rauchmann B-S, Perneczky R. Dysfunction of the blood\u2013brain barrier in Alzheimer\u2019s disease: evidence from human studies. Neuropathol Appl Neurobio. 2022;48(3):e12782. https:\/\/doi.org\/10.1111\/nan.12782.","DOI":"10.1111\/nan.12782"},{"key":"812_CR7","doi-asserted-by":"publisher","unstructured":"Iliff JJ, Wang M, Liao Y, Plogg BA, Peng W, Gundersen GA, et al. A paravascular pathway facilitates CSF flow through the brain parenchyma and the clearance of interstitial solutes, including amyloid \u03b2. Sci Transl Med. 2012;4(147):147ra111. https:\/\/doi.org\/10.1126\/scitranslmed.3003748.","DOI":"10.1126\/scitranslmed.3003748"},{"issue":"5","key":"812_CR8","doi-asserted-by":"publisher","first-page":"648","DOI":"10.1002\/ana.23648","volume":"72","author":"R Daneman","year":"2012","unstructured":"Daneman R. The blood\u2013brain barrier in health and disease. Ann Neurol. 2012;72(5):648\u201372. https:\/\/doi.org\/10.1002\/ana.23648.","journal-title":"Ann Neurol"},{"issue":"2","key":"812_CR9","doi-asserted-by":"publisher","first-page":"279","DOI":"10.3390\/pharmaceutics14020279","volume":"14","author":"MJ Ramalho","year":"2022","unstructured":"Ramalho MJ, Loureiro JA, Coelho MAN, Pereira MC. Transferrin receptor-targeted nanocarriers: overcoming barriers to treat glioblastoma. Pharmaceutics. 2022;14(2):279. https:\/\/doi.org\/10.3390\/pharmaceutics14020279.","journal-title":"Pharmaceutics"},{"key":"812_CR10","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1016\/j.bbi.2018.07.017","volume":"73","author":"SE Storck","year":"2018","unstructured":"Storck SE, Hartz AMS, Bernard J, Wolf A, Kachlmeier A, Mahringer A, et al. The concerted amyloid-beta clearance of LRP1 and ABCB1\/P-gp across the blood-brain barrier is linked by PICALM. Brain Behav Immun. 2018;73:21\u201333. https:\/\/doi.org\/10.1016\/j.bbi.2018.07.017.","journal-title":"Brain Behav Immun"},{"issue":"1","key":"812_CR11","doi-asserted-by":"publisher","first-page":"2261509","DOI":"10.1080\/19420862.2023.2261509","volume":"15","author":"HP Grimm","year":"2023","unstructured":"Grimm HP, Schumacher V, Sch\u00e4fer M, Imhof-Jung S, Freskg\u00e5rd P-O, Brady K, et al. Delivery of the Brainshuttle\u2122 amyloid-beta antibody fusion trontinemab to non-human primate brain and projected efficacious dose regimens in humans. Mabs-austin. 2023;15(1):2261509. https:\/\/doi.org\/10.1080\/19420862.2023.2261509.","journal-title":"Mabs-austin"},{"key":"812_CR12","doi-asserted-by":"publisher","unstructured":"Kariolis MS, Wells RC, Getz JA, Kwan W, Mahon CS, Tong R, et al. Brain delivery of therapeutic proteins using an Fc fragment blood-brain barrier transport vehicle in mice and monkeys. Sci Transl Med. 2020;12(545). https:\/\/doi.org\/10.1126\/scitranslmed.aay1359.","DOI":"10.1126\/scitranslmed.aay1359"},{"issue":"7","key":"812_CR13","doi-asserted-by":"publisher","first-page":"100204","DOI":"10.1016\/j.tjpad.2025.100204","volume":"12","author":"LAD Koning","year":"2025","unstructured":"Koning LAD, Vazquez-Matias DA, Beaino W, Vugts DJ, van Dongen GAMS, van der Flier WM, et al. Drug delivery strategies to cross the blood-brain barrier in Alzheimer\u2019s disease: a comprehensive review on three promising strategies. J Sport Hist Prev Alzheimers Disease. 2025;12(7):100204. https:\/\/doi.org\/10.1016\/j.tjpad.2025.100204.","journal-title":"J Sport Hist Prev Alzheimers Disease"},{"issue":"1","key":"812_CR14","doi-asserted-by":"publisher","first-page":"38","DOI":"10.3390\/pharmaceutics13010038","volume":"13","author":"GR Topal","year":"2020","unstructured":"Topal GR, M\u00e9sz\u00e1ros M, Porkol\u00e1b G, Szecsk\u00f3 A, Polg\u00e1r TF, Sikl\u00f3s L, et al. ApoE-targeting increases the transfer of solid lipid nanoparticles with donepezil cargo across a culture model of the blood\u2013brain barrier. Pharmaceutics. 2020;13(1):38. https:\/\/doi.org\/10.3390\/pharmaceutics13010038.","journal-title":"Pharmaceutics"},{"key":"812_CR15","doi-asserted-by":"publisher","unstructured":"Fritzen L, Wienken K, Wagner L, Kurtyka M, Vogel K, K\u00f6rbelin J, et al. Truncated mini LRP1 transports cargo from luminal to basolateral side across the blood brain barrier. Fluids Barriers CNS. 2024;21(1). https:\/\/doi.org\/10.1186\/s12987-024-00573-1.","DOI":"10.1186\/s12987-024-00573-1"},{"issue":"1","key":"812_CR16","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1038\/s41392-025-02426-1","volume":"10","author":"J Chen","year":"2025","unstructured":"Chen J, Xiang P, Duro-Castano A, Cai H, Guo B, Liu X, et al. Rapid amyloid-\u03b2 clearance and cognitive recovery through multivalent modulation of blood\u2013brain barrier transport. Sig Transduct Target Ther. 2025;10(1):331. https:\/\/doi.org\/10.1038\/s41392-025-02426-1.","journal-title":"Sig Transduct Target Ther"},{"issue":"6","key":"812_CR17","doi-asserted-by":"publisher","first-page":"3724","DOI":"10.1007\/s12035-023-03733-w","volume":"61","author":"M Pourhadi","year":"2024","unstructured":"Pourhadi M, Zali H, Ghasemi R, Faizi M, Mojab F, Soufi Zomorrod M. Restoring synaptic function: how intranasal delivery of 3D-Cultured hUSSC exosomes improve learning and memory deficits in Alzheimer\u2019s disease. Mol Neurobiol. 2024;61(6):3724\u201341. https:\/\/doi.org\/10.1007\/s12035-023-03733-w.","journal-title":"Mol Neurobiol"},{"key":"812_CR18","doi-asserted-by":"publisher","unstructured":"Barker SJ, Thayer MB, Kim C, Tatarakis D, Simon MJ, Dial R, et al. Targeting the transferrin receptor to transport antisense oligonucleotides across the mammalian blood-brain barrier. Sci Transl Med. 2024;16(760):eadi2245. https:\/\/doi.org\/10.1126\/scitranslmed.adi2245.","DOI":"10.1126\/scitranslmed.adi2245"},{"key":"812_CR19","unstructured":"Pokhrel B, Pellegrini MV, Levine SN. StatPearls. PCSK9 inhibitors (treasure island (FL)). 2025."},{"issue":"4","key":"812_CR20","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1007\/s00018-022-04237-x","volume":"79","author":"AD Mazura","year":"2022","unstructured":"Mazura AD, Ohler A, Storck SE, Kurtyka M, Scharfenberg F, Weggen S, et al. PCSK9 acts as a key regulator of A\u03b2 clearance across the blood\u2013brain barrier. Cell Mol Life Sci. 2022;79(4):212. https:\/\/doi.org\/10.1007\/s00018-022-04237-x.","journal-title":"Cell. Mol. Life Sci"},{"issue":"1","key":"812_CR21","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1186\/s12883-025-04302-5","volume":"25","author":"Y Wang","year":"2025","unstructured":"Wang Y, Yu Q, Chen B, Zhou J, Li Z, Liao W, et al. Two cases of amyloid-related Imaging Abnormalities (ARIA) following lecanemab treatment for alzheimer\u2019s disease and a literature review. BMC Neurol. 2025;25(1):281. https:\/\/doi.org\/10.1186\/s12883-025-04302-5.","journal-title":"BMC Neurol"},{"issue":"1","key":"812_CR22","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1186\/s13195-022-01110-8","volume":"14","author":"RJ Bateman","year":"2022","unstructured":"Bateman RJ, Cummings J, Schobel S, Salloway S, Vellas B, Boada M, et al. Gantenerumab: an anti-amyloid monoclonal antibody with potential disease-modifying effects in early Alzheimer\u2019s disease. Alz Res Ther. 2022;14(1):178. https:\/\/doi.org\/10.1186\/s13195-022-01110-8.","journal-title":"Alz Res Ther"},{"issue":"2","key":"812_CR23","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1016\/j.neuron.2008.01.003","volume":"57","author":"BV Zlokovic","year":"2008","unstructured":"Zlokovic BV. The blood-brain barrier in health and chronic neurodegenerative disorders. Neuron. 2008;57(2):178\u2013201. https:\/\/doi.org\/10.1016\/j.neuron.2008.01.003.","journal-title":"Neuron"},{"issue":"12","key":"812_CR24","doi-asserted-by":"publisher","first-page":"723","DOI":"10.1038\/nrn3114","volume":"12","author":"BV Zlokovic","year":"2011","unstructured":"Zlokovic BV. Neurovascular pathways to neurodegeneration in Alzheimer\u2019s disease and other disorders. Nat. Rev. Neurosci. 2011;12(12):723\u201338. https:\/\/doi.org\/10.1038\/nrn3114.","journal-title":"Nat. Rev. Neurosci"},{"issue":"10","key":"812_CR25","doi-asserted-by":"publisher","first-page":"1889","DOI":"10.1089\/ars.2010.3474","volume":"14","author":"C Rink","year":"2011","unstructured":"Rink C, Khanna S. Significance of brain tissue oxygenation and the arachidonic acid cascade in stroke. Antioxid Redox Signal. 2011;14(10):1889\u2013903. https:\/\/doi.org\/10.1089\/ars.2010.3474.","journal-title":"Antioxid Redox Signal"},{"key":"812_CR26","unstructured":"Das Sauerstoff-Bedurfnis des Organismus:Eine Farbenanalytische Studie. 1885."},{"key":"812_CR27","unstructured":"Goldmann EE. Vitalf\u00e4rbung am Zentralnervensystem: Beitrag zur Physio-Pathologie des Plexux Chorioideus und der Hirnh\u00e4ute. (No Title). https:\/\/cir.nii.ac.jp\/crid\/1130000796055180160."},{"issue":"5","key":"812_CR28","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1016\/0166-2236(90)90043-A","volume":"13","author":"W Risau","year":"1990","unstructured":"Risau W, Wolburg H. Development of the blood-brain barrier. Trends Neurosciences. 1990;13(5):174\u201378. https:\/\/doi.org\/10.1016\/0166-2236(90)90043-A.","journal-title":"Trends Neurosciences"},{"issue":"4","key":"812_CR29","doi-asserted-by":"publisher","first-page":"545","DOI":"10.1016\/j.neuint.2003.11.006","volume":"45","author":"NJ Abbott","year":"2004","unstructured":"Abbott NJ. Evidence for bulk flow of brain interstitial fluid: significance for physiology and pathology. Neurochemistry Int. 2004;45(4):545\u201352. https:\/\/doi.org\/10.1016\/j.neuint.2003.11.006.","journal-title":"Neurochemistry Int"},{"key":"812_CR30","first-page":"97","volume":"25","author":"MW Bradbury","year":"1963","unstructured":"Bradbury MW, Stubbs J, Hughes IE, Parker P. The distribution of potassium, sodium, chloride and urea between lumbar cerebrospinal fluid and blood serum in human subjects. Clin Sci. 1963;25:97\u2013105.","journal-title":"Clin Sci"},{"issue":"5","key":"812_CR31","first-page":"600","volume":"60","author":"J Bernacki","year":"2008","unstructured":"Bernacki J, Dobrowolska A, Nierwi\u0144ska K, Ma\u0142ecki A. Physiology and pharmacological role of the blood-brain barrier. Pharmacol Rep. 2008;60(5):600\u201322.","journal-title":"Pharmacol Rep"},{"issue":"9","key":"812_CR32","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1016\/S0166-2236(00)01617-9","volume":"23","author":"MB Gingrich","year":"2000","unstructured":"Gingrich MB, Traynelis SF. Serine proteases and brain damage \u2013 is there a link? Trends Neurosciences. 2000;23(9):399\u2013407. https:\/\/doi.org\/10.1016\/S0166-2236(00)01617-9.","journal-title":"Trends Neurosciences"},{"issue":"1","key":"812_CR33","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/j.nbd.2009.07.030","volume":"37","author":"NJ Abbott","year":"2010","unstructured":"Abbott NJ, Patabendige AAK, Dolman DEM, Yusof SR, Begley DJ. Structure and function of the blood\u2013brain barrier. Neurobiol Disease. 2010;37(1):13\u201325. https:\/\/doi.org\/10.1016\/j.nbd.2009.07.030.","journal-title":"Neurobiol Disease"},{"issue":"4","key":"812_CR34","doi-asserted-by":"publisher","first-page":"955","DOI":"10.1016\/j.neuroscience.2004.07.003","volume":"129","author":"PD Brown","year":"2004","unstructured":"Brown PD, Davies SL, Speake T, Millar ID. Molecular mechanisms of cerebrospinal fluid production. Neuroscience. 2004;129(4):955\u201368. https:\/\/doi.org\/10.1016\/j.neuroscience.2004.07.003.","journal-title":"Neuroscience"},{"key":"812_CR35","doi-asserted-by":"crossref","unstructured":"Cserr HF, Patlak CS. Secretion and bulk flow of interstitial fluid. In: Bradbury MWB, editor. Physiology and pharmacology of the blood-brain Barrier. Handbook of experimental pharmacology. Vol. 103 vol., 103. Berlin, Heidelberg: Springer Berlin Heidelberg; 1992. p. 245\u201361.","DOI":"10.1007\/978-3-642-76894-1_9"},{"issue":"1","key":"812_CR36","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1038\/nrn1824","volume":"7","author":"NJ Abbott","year":"2006","unstructured":"Abbott NJ, R\u00f6nnb\u00e4ck L, Hansson E. Astrocyte\u2013endothelial interactions at the blood\u2013brain barrier. Nat. Rev. Neurosci. 2006;7(1):41\u201353. https:\/\/doi.org\/10.1038\/nrn1824.","journal-title":"Nat. Rev. Neurosci"},{"key":"812_CR37","unstructured":"Principlesof neural science. 2000."},{"key":"812_CR38","unstructured":"Nag S, BegleyDavid J. Blood brain barrier, exchange of metabolites and gases. 2005. https:\/\/www.semanticscholar.org\/paper\/Blood-Brain-Barrier%2C-Exchange-of-metabolites-and-Nag-BegleyDavid\/0597329f2a5bc760b8d683049541a8a16d2962c7."},{"issue":"1","key":"812_CR39","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1146\/annurev.neuro.22.1.11","volume":"22","author":"LL Rubin","year":"1999","unstructured":"Rubin LL, Staddon JM. The cell biology of the blood-brain barrier. Annu. Rev. Neurosci. 1999;22(1):11\u201328. https:\/\/doi.org\/10.1146\/annurev.neuro.22.1.11.","journal-title":"Annu. Rev. Neurosci"},{"issue":"21","key":"812_CR40","doi-asserted-by":"publisher","first-page":"1809","DOI":"10.1212\/01.wnl.0000262031.18018.1a","volume":"68","author":"GL Bowman","year":"2007","unstructured":"Bowman GL, Kaye JA, Moore M, Waichunas D, Carlson NE, Quinn JF. Blood\u2013brain barrier impairment in Alzheimer disease. Neurology. 2007;68(21):1809\u201314. https:\/\/doi.org\/10.1212\/01.wnl.0000262031.18018.1a.","journal-title":"Neurology"},{"issue":"9157","key":"812_CR41","doi-asserted-by":"publisher","first-page":"981","DOI":"10.1016\/S0140-6736(99)00641-8","volume":"353","author":"BA Faucheux","year":"1999","unstructured":"Faucheux BA, Agid Y, Hirsch EC, Bonnet A-M. Blood vessels change in the mesencephalon of patients with Parkinson\u2019s disease. Lancet. 1999;353(9157):981\u201382. https:\/\/doi.org\/10.1016\/S0140-6736(99)00641-8.","journal-title":"Lancet"},{"issue":"2","key":"812_CR42","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1007\/BF00313720","volume":"231","author":"A Leonardi","year":"1984","unstructured":"Leonardi A, Abbruzzese G, Arata L, Cocito L, Vische M. Cerebrospinal fluid (CSF) findings in amyotrophic lateral sclerosis. J Neurol. 1984;231(2):75\u201378. https:\/\/doi.org\/10.1007\/BF00313720.","journal-title":"J Neurol"},{"key":"812_CR43","doi-asserted-by":"publisher","unstructured":"Wilhelm I, Ny\u00fal-T\u00f3th \u00c1, Suciu M, Hermenean A, Krizbai IA. Heterogeneity of the blood-brain barrier. Tissue Barriers. 2016;4(1):e1143544. https:\/\/doi.org\/10.1080\/21688370.2016.1143544.","DOI":"10.1080\/21688370.2016.1143544"},{"key":"812_CR44","doi-asserted-by":"publisher","first-page":"1024","DOI":"10.3389\/fimmu.2020.01024","volume":"11","author":"L-R Liu","year":"2020","unstructured":"Liu L-R, Liu J-C, Bao J-S, Bai Q-Q, Wang G-Q. Interaction of microglia and astrocytes in the neurovascular unit. Front. Immunol. 2020;11:1024. https:\/\/doi.org\/10.3389\/fimmu.2020.01024.","journal-title":"Front. Immunol"},{"issue":"1","key":"812_CR45","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1093\/brain\/awab311","volume":"145","author":"MM Salman","year":"2022","unstructured":"Salman MM, Kitchen P, Halsey A, Wang MX, T\u00f6rnroth-Horsefield S, Conner AC, et al. Emerging roles for dynamic aquaporin-4 subcellular relocalization in CNS water homeostasis. Brain: J Neurol. 2022;145(1):64\u201375. https:\/\/doi.org\/10.1093\/brain\/awab311.","journal-title":"Brain: J Neurol"},{"issue":"1","key":"812_CR46","doi-asserted-by":"publisher","first-page":"19718","DOI":"10.1038\/s41598-019-56075-w","volume":"9","author":"MD Laksitorini","year":"2019","unstructured":"Laksitorini MD, Yathindranath V, Xiong W, Hombach-Klonisch S, Miller DW. Modulation of Wnt\/\u03b2-catenin signaling promotes blood-brain barrier phenotype in cultured brain endothelial cells. Sci Rep. 2019;9(1):19718. https:\/\/doi.org\/10.1038\/s41598-019-56075-w.","journal-title":"Sci Rep"},{"issue":"3","key":"812_CR47","doi-asserted-by":"publisher","first-page":"571","DOI":"10.3390\/ijms20030571","volume":"20","author":"S Michinaga","year":"2019","unstructured":"Michinaga S, Koyama Y. Dual roles of astrocyte-derived factors in regulation of blood-brain barrier function after brain damage. IJMS. 2019;20(3):571. https:\/\/doi.org\/10.3390\/ijms20030571.","journal-title":"IJMS"},{"issue":"1","key":"812_CR48","doi-asserted-by":"publisher","first-page":"578","DOI":"10.1111\/j.1749-6632.1991.tb15667.x","volume":"633","author":"J Neuhaus","year":"1991","unstructured":"Neuhaus J, Risau W, Wolburg H. Induction of blood-brain barrier characteristics in bovine brain endothelial cells by rat astroglial cells in transfilter coculture a. Ann New Y Acad Sci. 1991;633(1):578\u201380. https:\/\/pubmed.ncbi.nlm.nih.gov\/1789585\/.","journal-title":"Ann New Y Acad Sci"},{"issue":"24","key":"812_CR49","doi-asserted-by":"publisher","first-page":"17146","DOI":"10.3390\/ijms242417146","volume":"24","author":"DR Manu","year":"2023","unstructured":"Manu DR, Slevin M, Barcutean L, Forro T, Boghitoiu T, Balasa R. Astrocyte involvement in blood\u2013brain barrier function: a critical update highlighting novel, complex, neurovascular interactions. IJMS. 2023;24(24):17146. https:\/\/doi.org\/10.3390\/ijms242417146.","journal-title":"IJMS"},{"issue":"1","key":"812_CR50","doi-asserted-by":"publisher","first-page":"420","DOI":"10.1111\/j.1749-6632.1991.tb15631.x","volume":"633","author":"LL Rubin","year":"1991","unstructured":"Rubin LL, Barbu K, Bard F, Cannon C, Hall DE, Horner H, et al. Differentiation of brain endothelial cells in cell culture. Ann New Y Acad Sci. 1991;633(1):420\u201325. https:\/\/doi.org\/10.1111\/j.1749-6632.1991.tb15631.x.","journal-title":"Ann New Y Acad Sci"},{"issue":"7321","key":"812_CR51","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1038\/nature09613","volume":"468","author":"D Attwell","year":"2010","unstructured":"Attwell D, Buchan AM, Charpak S, Lauritzen M, MacVicar BA, Newman EA. Glial and neuronal control of brain blood flow. Nature. 2010;468(7321):232\u201343. https:\/\/doi.org\/10.1038\/nature09613.","journal-title":"Nature"},{"issue":"5","key":"812_CR52","doi-asserted-by":"publisher","first-page":"782","DOI":"10.1016\/j.neuron.2011.08.009","volume":"71","author":"GC Petzold","year":"2011","unstructured":"Petzold GC, Murthy VN. Role of astrocytes in neurovascular coupling. Neuron. 2011;71(5):782\u201397. https:\/\/doi.org\/10.1016\/j.neuron.2011.08.009.","journal-title":"Neuron"},{"issue":"10","key":"812_CR53","doi-asserted-by":"publisher","first-page":"712","DOI":"10.1038\/nri2852","volume":"10","author":"L Sorokin","year":"2010","unstructured":"Sorokin L. The impact of the extracellular matrix on inflammation. Nat Rev Immunol. 2010;10(10):712\u201323. https:\/\/doi.org\/10.1038\/nri2852.","journal-title":"Nat Rev Immunol"},{"issue":"4","key":"812_CR54","doi-asserted-by":"publisher","first-page":"1007","DOI":"10.1084\/jem.20051342","volume":"203","author":"S Agrawal","year":"2006","unstructured":"Agrawal S, Anderson P, Durbeej M, van Rooijen N, Ivars F, Opdenakker G, et al. Dystroglycan is selectively cleaved at the parenchymal basement membrane at sites of leukocyte extravasation in experimental autoimmune encephalomyelitis. J Exp Med. 2006;203(4):1007\u201319. https:\/\/doi.org\/10.1084\/jem.20051342.","journal-title":"J Exp Med"},{"issue":"3","key":"812_CR55","doi-asserted-by":"publisher","first-page":"502","DOI":"10.1093\/brain\/awy339","volume":"142","author":"L Bertrand","year":"2019","unstructured":"Bertrand L, Cho HJ, Toborek M. Blood\u2013brain barrier pericytes as a target for HIV-1 infection. Brain: J Neurol. 2019;142(3):502\u201311. https:\/\/doi.org\/10.1093\/brain\/awy339.","journal-title":"Brain: J Neurol"},{"issue":"2","key":"812_CR56","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1016\/j.devcel.2011.07.001","volume":"21","author":"A Armulik","year":"2011","unstructured":"Armulik A, Genov\u00e9 G, Betsholtz C. Pericytes: developmental, physiological, and pathological perspectives, problems, and promises. Dev Cell. 2011;21(2):193\u2013215. https:\/\/doi.org\/10.1016\/j.devcel.2011.07.001.","journal-title":"Dev Cell"},{"issue":"7","key":"812_CR57","doi-asserted-by":"publisher","first-page":"1089","DOI":"10.1038\/s41593-019-0434-z","volume":"22","author":"AM Nikolakopoulou","year":"2019","unstructured":"Nikolakopoulou AM, Montagne A, Kisler K, Dai Z, Wang Y, Huuskonen MT, et al. Pericyte loss leads to circulatory failure and pleiotrophin depletion causing neuron loss. Nat. Neurosci. 2019;22(7):1089\u201398. https:\/\/doi.org\/10.1038\/s41593-019-0434-z.","journal-title":"Nat. Neurosci"},{"key":"812_CR58","doi-asserted-by":"publisher","unstructured":"Elfont RM, Sundaresan PR, Sladek CD. Adrenergic receptors on cerebral microvessels: pericyte contribution. Am J Physiol-Regul, Intgr Comp Physiol. 1989;256(1):R224\u201330. https:\/\/doi.org\/10.1152\/ajpregu.1989.256.1.R224.","DOI":"10.1152\/ajpregu.1989.256.1.R224"},{"issue":"2","key":"812_CR59","doi-asserted-by":"publisher","first-page":"286","DOI":"10.1016\/0006-8993(93)90996-Z","volume":"606","author":"L Song","year":"1993","unstructured":"Song L, Wilk E, Wilk S, Healy DP. Localization of immunoreactive glutamyl aminopeptidase in rat brain. I. Association with cerebral microvessels. Brain Res. 1993;606(2):286\u201394. https:\/\/doi.org\/10.1016\/0006-8993(93)90996-Z.","journal-title":"Brain Res"},{"issue":"1","key":"812_CR60","first-page":"53","volume":"40","author":"V Benagiano","year":"1996","unstructured":"Benagiano V, Virgintino D, Maiorano E, Rizzi A, Palombo S, Roncali L, et al. VIP-like immunoreactivity within neurons and perivascular neuronal processes of the human cerebral cortex. Eur J Histochem. 1996;40(1):53\u201356.","journal-title":"Eur J Histochem"},{"issue":"4","key":"812_CR61","doi-asserted-by":"publisher","first-page":"464","DOI":"10.1097\/00004647-199704000-00012","volume":"17","author":"MP Dehouck","year":"1997","unstructured":"Dehouck MP, Vigne P, Torpier G, Breittmayer JP, Cecchelli R, Frelin C. Endothelin-1 as a mediator of endothelial cell\u2013pericyte interactions in bovine brain capillaries. J Cereb Blood Flow Metab. 1997;17(4):464\u201369. https:\/\/doi.org\/10.1097\/00004647-199704000-00012.","journal-title":"J Cereb Blood Flow Metab"},{"issue":"2","key":"812_CR62","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1016\/0006-8993(88)90453-2","volume":"474","author":"EJ van Zwieten","year":"1988","unstructured":"van Zwieten EJ, Ravid R, Swaab DF, van de Woude T. Immunocytochemically stained vasopressin binding sites on blood vessels in the rat brain. Brain Res. 1988;474(2):369\u201373. https:\/\/doi.org\/10.1016\/0006-8993(88)90453-2.","journal-title":"Brain Res"},{"issue":"2","key":"812_CR63","doi-asserted-by":"publisher","first-page":"600","DOI":"10.3390\/biomedicines11020600","volume":"11","author":"SA Dabravolski","year":"2023","unstructured":"Dabravolski SA, Andreeva ER, Eremin II, Markin AM, Nadelyaeva II, Orekhov AN, et al. The role of pericytes in regulation of innate and adaptive immunity. Biomedicines. 2023;11(2):600. https:\/\/doi.org\/10.3390\/biomedicines11020600.","journal-title":"Biomedicines"},{"issue":"1","key":"812_CR64","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1186\/s12987-020-00230-3","volume":"17","author":"H Kadry","year":"2020","unstructured":"Kadry H, Noorani B, Cucullo L. A blood\u2013brain barrier overview on structure, function, impairment, and biomarkers of integrity. Fluids Barriers CNS. 2020;17(1):69. https:\/\/doi.org\/10.1186\/s12987-020-00230-3.","journal-title":"Fluids Barriers CNS"},{"issue":"1","key":"812_CR65","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1113\/jphysiol.1990.sp018243","volume":"429","author":"AM Butt","year":"1990","unstructured":"Butt AM, Jones HC, Abbott NJ. Electrical resistance across the blood-brain barrier in anaesthetized rats: a developmental study. J Physiol. 1990;429(1):47\u201362. https:\/\/doi.org\/10.1113\/jphysiol.1990.sp018243.","journal-title":"J Physiol"},{"issue":"3","key":"812_CR66","doi-asserted-by":"publisher","first-page":"869","DOI":"10.1152\/physrev.00035.2003","volume":"84","author":"G Bazzoni","year":"2004","unstructured":"Bazzoni G, Dejana E. Endothelial cell-to-cell junctions: molecular organization and role in vascular homeostasis. Physiol Rev. 2004;84(3):869\u2013901. https:\/\/pubmed.ncbi.nlm.nih.gov\/15269339\/.","journal-title":"Physiol Rev"},{"issue":"4","key":"812_CR67","doi-asserted-by":"publisher","first-page":"891","DOI":"10.1083\/jcb.147.4.891","volume":"147","author":"M Furuse","year":"1999","unstructured":"Furuse M, Sasaki H, Tsukita S. Manner of interaction of heterogeneous claudin species within and between tight junction strands. J Cell Biol. 1999;147(4):891\u2013903. https:\/\/doi.org\/10.1083\/jcb.147.4.891.","journal-title":"J Cell Biol"},{"issue":"1","key":"812_CR68","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.nbd.2003.12.016","volume":"16","author":"P Ballabh","year":"2004","unstructured":"Ballabh P, Braun A, Nedergaard M. The blood\u2013brain barrier: an overview. Neurobiol Disease. 2004;16(1):1\u201313. https:\/\/doi.org\/10.1016\/j.nbd.2003.12.016.","journal-title":"Neurobiol Disease"},{"issue":"3","key":"812_CR69","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1007\/s004010000180","volume":"100","author":"S Liebner","year":"2000","unstructured":"Liebner S, Fischmann A, Rascher G, Duffner F, Grote E-H, Kalbacher H, et al. Claudin-1 and claudin-5 expression and tight junction morphology are altered in blood vessels of human glioblastoma multiforme. Acta Neuropathologica. 2000;100(3):323\u201331. https:\/\/doi.org\/10.1007\/s004010000180.","journal-title":"Acta Neuropathologica"},{"issue":"13","key":"812_CR70","doi-asserted-by":"publisher","first-page":"3699","DOI":"10.1182\/blood.V98.13.3699","volume":"98","author":"M Aurrand-Lions","year":"2001","unstructured":"Aurrand-Lions M, Johnson-Leger C, Wong C, Du Pasquier L, Imhof BA. Heterogeneity of endothelial junctions is reflected by differential expression and specific subcellular localization of the three JAM family members. Blood. 2001;98(13):3699\u2013707. https:\/\/doi.org\/10.1182\/blood.V98.13.3699.","journal-title":"Blood"},{"issue":"40","key":"812_CR71","doi-asserted-by":"publisher","first-page":"30970","DOI":"10.1074\/jbc.M003946200","volume":"275","author":"G Bazzoni","year":"2000","unstructured":"Bazzoni G, Mart\u0131\u0300nez-Estrada OM, Mueller F, Nelboeck P, Schmid G, Bartfai T, et al. Homophilic interaction of junctional adhesion molecule. J Biol Chem. 2000;275(40):30970\u201376. https:\/\/doi.org\/10.1074\/jbc.M003946200.","journal-title":"J Biol Chem"},{"key":"812_CR72","doi-asserted-by":"publisher","unstructured":"Mitic LL, van Itallie CM, Anderson JM. Molecular physiology and pathophysiology of tight junctions I. Tight junction structure and function: lessons from mutant animals and proteins. Am J Physiol-Gastr L. 2000;279(2):G250\u20134. https:\/\/doi.org\/10.1152\/ajpgi.2000.279.2.G250.","DOI":"10.1152\/ajpgi.2000.279.2.G250"},{"issue":"36","key":"812_CR73","doi-asserted-by":"publisher","first-page":"27979","DOI":"10.1074\/jbc.M002363200","volume":"275","author":"K Ebnet","year":"2000","unstructured":"Ebnet K, Schulz CU, Meyer Zu Brickwedde MK, Pendl GG, Vestweber D. Junctional adhesion molecule interacts with the PDZ domain-containing proteins AF-6 and ZO-1. J Biol Chem. 2000;275(36):27979\u201388. https:\/\/doi.org\/10.1074\/jbc.M002363200.","journal-title":"J Biol Chem"},{"issue":"6","key":"812_CR74","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1016\/S1537-1891(02)00200-8","volume":"38","author":"H Wolburg","year":"2002","unstructured":"Wolburg H, Lippoldt A. Tight junctions of the blood\u2013brain barrier. Vascul Pharmacol. 2002;38(6):323\u201337. https:\/\/doi.org\/10.1016\/S1537-1891(02)00200-8.","journal-title":"Vascul Pharmacol"},{"issue":"03","key":"812_CR75","doi-asserted-by":"publisher","first-page":"595","DOI":"10.1160\/TH03-09-0582","volume":"91","author":"S Raab","year":"2004","unstructured":"Raab S, Beck H, Gaumann A, Y\u00fcce A, Gerber H-P, Plate K, et al. Impaired brain angiogenesis and neuronal apoptosis induced by conditional homozygous inactivation of vascular endothelial growth factor. Thromb Haemost. 2004;91(03):595\u2013605. https:\/\/doi.org\/10.1160\/TH03-09-0582.","journal-title":"Thromb Haemost"},{"issue":"2","key":"812_CR76","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1016\/j.devcel.2009.01.015","volume":"16","author":"L-K Phng","year":"2009","unstructured":"Phng L-K, Gerhardt H. Angiogenesis: a team effort coordinated by notch. Dev Cell. 2009;16(2):196\u2013208. https:\/\/doi.org\/10.1016\/j.devcel.2009.01.015.","journal-title":"Dev Cell"},{"issue":"5","key":"812_CR77","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1038\/nrc2389","volume":"8","author":"A Klaus","year":"2008","unstructured":"Klaus A, Birchmeier W. Wnt signalling and its impact on development and cancer. Nat Rev Cancer. 2008;8(5):387\u201398. https:\/\/doi.org\/10.1038\/nrc2389.","journal-title":"Nat Rev Cancer"},{"issue":"3","key":"812_CR78","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1083\/jcb.200806024","volume":"183","author":"S Liebner","year":"2008","unstructured":"Liebner S, Corada M, Bangsow T, Babbage J, Taddei A, Czupalla CJ, et al. Wnt\/\u03b2-catenin signaling controls development of the blood\u2013brain barrier. J Cell Biol. 2008;183(3):409\u201317. https:\/\/doi.org\/10.1083\/jcb.200806024.","journal-title":"J Cell Biol"},{"issue":"7","key":"812_CR79","doi-asserted-by":"publisher","first-page":"416","DOI":"10.1038\/nrm3598","volume":"14","author":"J Briscoe","year":"2013","unstructured":"Briscoe J, Th\u00e9rond PP. The mechanisms of hedgehog signalling and its roles in development and disease. Nat Rev Mol Cell Biol. 2013;14(7):416\u201329. https:\/\/idp.nature.com\/authorize\/casa?redirect_uri=https:\/\/www.nature.com\/articles\/nrm3598%26casa_token=s80jrn9l0kuaaaaa:fsq1jd1_jkwadpczshtcyc6tnzyrrwgjtjim_yrujktovpew3xrcyyf5xr5zmiq5nv_xilpkqdbecy0a7w.","journal-title":"Nat Rev Mol Cell Biol"},{"issue":"6063","key":"812_CR80","doi-asserted-by":"publisher","first-page":"1727","DOI":"10.1126\/science.1206936","volume":"334","author":"JI Alvarez","year":"2011","unstructured":"Alvarez JI, Dodelet-Devillers A, Kebir H, Ifergan I, Fabre PJ, Terouz S, et al. The hedgehog pathway promotes blood-brain barrier integrity and CNS immune quiescence. Sci (New Y, N.Y.). 2011;334(6063):1727\u201331. https:\/\/doi.org\/10.1126\/science.1206936.","journal-title":"Sci (New Y, N.Y.)"},{"issue":"14","key":"812_CR81","doi-asserted-by":"publisher","first-page":"3047","DOI":"10.1242\/dev.126.14.3047","volume":"126","author":"M Hellstr\u00f6m","year":"1999","unstructured":"Hellstr\u00f6m M, Kal\u00e9n M, Lindahl P, Abramsson A, Betsholtz C. Role of PDGF-B and PDGFR-\u03b2 in recruitment of vascular smooth muscle cells and pericytes during embryonic blood vessel formation in the mouse. Devel (Cambridge, Engl). 1999;126(14):3047\u201355. https:\/\/doi.org\/10.1242\/dev.126.14.3047.","journal-title":"Devel (Cambridge, Engl)"},{"issue":"7323","key":"812_CR82","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1038\/nature09522","volume":"468","author":"A Armulik","year":"2010","unstructured":"Armulik A, Genov\u00e9 G, M\u00e4e M, Nisancioglu MH, Wallgard E, Niaudet C, et al. Pericytes regulate the blood\u2013brain barrier. Nature. 2010;468(7323):557\u201361. https:\/\/doi.org\/10.1038\/nature09522.","journal-title":"Nature"},{"issue":"2","key":"812_CR83","doi-asserted-by":"publisher","first-page":"641","DOI":"10.1073\/pnas.0805165106","volume":"106","author":"R Daneman","year":"2009","unstructured":"Daneman R, Agalliu D, Zhou L, Kuhnert F, Kuo CJ, Barres BA. Wnt\/\u03b2-catenin signaling is required for CNS, but not non-CNS, angiogenesis. Proc Natl Acad Sci USA. 2009;106(2):641\u201346. https:\/\/doi.org\/10.1073\/pnas.0805165106.","journal-title":"Proc Natl Acad Sci USA"},{"issue":"10","key":"812_CR84","doi-asserted-by":"publisher","first-page":"1143","DOI":"10.4155\/tde.14.67","volume":"5","author":"M Laksitorini","year":"2014","unstructured":"Laksitorini M, Prasasty VD, Kiptoo PK, Siahaan TJ. Pathways and progress in improving drug delivery through the intestinal mucosa and blood\u2013brain barriers. Ther Deliv. 2014;5(10):1143\u201363. https:\/\/doi.org\/10.4155\/tde.14.67.","journal-title":"Ther Deliv"},{"issue":"1","key":"812_CR85","doi-asserted-by":"publisher","first-page":"3611","DOI":"10.1038\/ncomms4611","volume":"5","author":"G Frost","year":"2014","unstructured":"Frost G, Sleeth ML, Sahuri-Arisoylu M, Lizarbe B, Cerdan S, Brody L, et al. The short-chain fatty acid acetate reduces appetite via a central homeostatic mechanism. Nat Commun. 2014;5(1):3611. https:\/\/doi.org\/10.1038\/ncomms4611.","journal-title":"Nat Commun"},{"issue":"6","key":"812_CR86","doi-asserted-by":"publisher","first-page":"1629","DOI":"10.1152\/ajplegacy.1971.221.6.1629","volume":"221","author":"WH Oldendorf","year":"1971","unstructured":"Oldendorf WH. Brain uptake of radiolabeled amino acids, amines, and hexoses after arterial injection. Am J Physiol-Leg Content. 1971;221(6):1629\u201339. https:\/\/doi.org\/10.1152\/ajplegacy.1971.221.6.1629.","journal-title":"Am J Physiol-Leg Content"},{"issue":"1","key":"812_CR87","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1016\/0005-2736(75)90347-8","volume":"401","author":"WM Pardridge","year":"1975","unstructured":"Pardridge WM, Oldendorf WH. Kinetic analysis of blood-brain barrier transport of amino acids. Biochim Et Biophys Acta (BBA) - Biomembr. 1975;401(1):128\u201336. https:\/\/doi.org\/10.1016\/0005-2736(75)90347-8.","journal-title":"Biochim Et Biophys Acta (BBA) - Biomembr"},{"issue":"1","key":"812_CR88","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1111\/j.1748-1716.2007.01793.x","volume":"193","author":"R Iceta","year":"2008","unstructured":"Iceta R, Aramayona JJ, Mesonero JE, Alcalde AI. Regulation of the human serotonin transporter mediated by long-term action of serotonin in Caco-2 cells. Acta Physiologica. 2008;193(1):57\u201365. https:\/\/doi.org\/10.1111\/j.1748-1716.2007.01793.x.","journal-title":"Acta Physiologica"},{"key":"812_CR89","doi-asserted-by":"publisher","unstructured":"Gill RK, Anbazhagan AN, Esmaili A, Kumar A, Nazir S, Malakooti J, et al. Epidermal growth factor upregulates serotonin transporter in human intestinal epithelial cells via transcriptional mechanisms. Am J Physiol-Gastr L. 2011;300(4):G627\u201336. https:\/\/doi.org\/10.1152\/ajpgi.00563.2010.","DOI":"10.1152\/ajpgi.00563.2010"},{"issue":"9","key":"812_CR90","doi-asserted-by":"publisher","first-page":"5057","DOI":"10.1021\/acs.analchem.4c06033","volume":"97","author":"B Bohl","year":"2025","unstructured":"Bohl B, Lei Y, Bewick GA, Hashemi P. Measurement of real-time serotonin dynamics from human-derived gut organoids. Anal. Chem. 2025;97(9):5057\u201365. https:\/\/doi.org\/10.1021\/acs.analchem.4c06033.","journal-title":"Anal. Chem"},{"issue":"1","key":"812_CR91","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1002\/ana.410080102","volume":"8","author":"JE Hardebo","year":"1980","unstructured":"Hardebo JE, Owman C. Barrier mechanisms for neurotransmitter monoamines and their precursors at the blood-brain interface. Ann Neurol. 1980;8(1):1\u201311. https:\/\/doi.org\/10.1002\/ana.410080102.","journal-title":"Ann Neurol"},{"issue":"1","key":"812_CR92","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1124\/dmd.32.1.132","volume":"32","author":"X Liu","year":"2004","unstructured":"Liu X, Tu M, Kelly RS, Chen C, Smith BJ. Development of a computational approach to predict blood-brain barrier permeability. Drug Metab Dispos: Biol Fate Chemicals. 2004;32(1):132\u201339. https:\/\/doi.org\/10.1124\/dmd.32.1.132.","journal-title":"Drug Metab Dispos: Biol Fate Chemicals"},{"issue":"3","key":"812_CR93","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1007\/s002329900434","volume":"165","author":"H Fischer","year":"1998","unstructured":"Fischer H, Gottschlich R, Seelig A. Blood-brain barrier permeation: molecular parameters governing passive diffusion. J Membr Biol. 1998;165(3):201\u201311. https:\/\/doi.org\/10.1007\/s002329900434.","journal-title":"J Membr Biol"},{"issue":"11","key":"812_CR94","doi-asserted-by":"publisher","first-page":"3285","DOI":"10.1172\/JCI25247","volume":"115","author":"JR Cirrito","year":"2005","unstructured":"Cirrito JR, et al. P-glycoprotein deficiency at the blood-brain barrier increases amyloid- deposition in an Alzheimer disease mouse model. J Clin Investigation. 2005;115(11):3285\u201390. https:\/\/doi.org\/10.1172\/JCI25247.","journal-title":"J Clin Investigation"},{"key":"812_CR95","doi-asserted-by":"publisher","unstructured":"May P, Bock HH, Herz J. Integration of endocytosis and signal transduction by lipoprotein receptors. Sci Signal. 2003;2003(176):pe12\u201312. https:\/\/doi.org\/10.1126\/scisignal.1762003pe12.","DOI":"10.1126\/scisignal.1762003pe12"},{"issue":"8","key":"812_CR96","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1038\/nrd4626","volume":"14","author":"L Lin","year":"2015","unstructured":"Lin L, Yee SW, Kim RB, Giacomini KM. SLC transporters as therapeutic targets: emerging opportunities. Nat Rev Drug Discov. 2015;14(8):543\u201360. https:\/\/doi.org\/10.1038\/nrd4626.","journal-title":"Nat Rev Drug Discov"},{"issue":"24","key":"812_CR97","doi-asserted-by":"publisher","first-page":"16615","DOI":"10.1021\/acs.jmedchem.3c01069","volume":"66","author":"C Jorgensen","year":"2023","unstructured":"Jorgensen C, Ulmschneider MB, Searson PC. Modeling substrate entry into the P-Glycoprotein efflux Pump at the blood\u2013brain barrier. J Med Chem. 2023;66(24):16615\u201327. https:\/\/doi.org\/10.1021\/acs.jmedchem.3c01069.","journal-title":"J Med Chem"},{"key":"812_CR98","doi-asserted-by":"publisher","unstructured":"Hladky SB, Barrand MA. Fluid and ion transfer across the blood\u2013brain and blood\u2013cerebrospinal fluid barriers; a comparative account of mechanisms and roles. Fluids Barriers CNS. 2016;13(1). https:\/\/doi.org\/10.1186\/s12987-016-0040-3.","DOI":"10.1186\/s12987-016-0040-3"},{"issue":"1","key":"812_CR99","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1111\/joim.13440","volume":"292","author":"S Rathi","year":"2022","unstructured":"Rathi S, Griffith JI, Zhang W, Zhang W, Oh J-H, Talele S, et al. The influence of the blood\u2013brain barrier in the treatment of brain tumours. J Intern Med. 2022;292(1):3\u201330. https:\/\/doi.org\/10.1111\/joim.13440.","journal-title":"J Intern Med"},{"issue":"4","key":"812_CR100","doi-asserted-by":"publisher","first-page":"476","DOI":"10.1172\/JCI101994","volume":"27","author":"SS Kety","year":"1948","unstructured":"Kety SS, Schmidt CF. THE NITROUS OXIDE METHOD FOR THE QUANTITATIVE DETERMINATION OF CEREBRAL BLOOD FLOW IN MAN: THEORY, PROCEDURE AND NORMAL VALUES 1. J. Clin. Invest. 1948;27(4):476\u201383. https:\/\/doi.org\/10.1172\/JCI101994.","journal-title":"J. Clin. Invest"},{"issue":"2","key":"812_CR101","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1161\/01.STR.11.2.141","volume":"11","author":"R Hemmingsen","year":"1980","unstructured":"Hemmingsen R, Hertz MM, Bolwig TG. Integrity of blood-brain barrier during ethanol intoxication and withdrawal in the rat: normal glucose transfer and permeability to Na+ and Cl-. Stroke. 1980;11(2):141\u201344. https:\/\/doi.org\/10.1161\/01.STR.11.2.141.","journal-title":"Stroke"},{"issue":"1","key":"812_CR102","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1172\/JCI109433","volume":"64","author":"WM Pardridge","year":"1979","unstructured":"Pardridge WM, Mietus LJ. Transport of steroid hormones through the rat blood-brain barrier. Primary role of albumin-bound hormone. J. Clin. Invest. 1979;64(1):145\u201354. https:\/\/doi.org\/10.1172\/JCI109433.","journal-title":"J. Clin. Invest"},{"key":"812_CR103","doi-asserted-by":"publisher","unstructured":"Al-Samir S, Kyriazi D, Yool AJ, Moser I, Kyriazi K, Gros G, et al. Aquaporin-1 acts as an O2 channel. The permeability of human and mouse red cell membranes for oxygen. Am J Physiol-Cell Physiol. 2025;328:C1605\u201322. https:\/\/doi.org\/10.1152\/ajpcell.00858.2024.","DOI":"10.1152\/ajpcell.00858.2024"},{"issue":"2","key":"812_CR104","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1038\/bjc.1993.54","volume":"67","author":"CK van Kalken","year":"1993","unstructured":"van Kalken CK, Broxterman HJ, Pinedo HM, Feller N, Dekker H, Lankelma J, et al. Cortisol is transported by the multidrug resistance gene product P-glycoprotein. Br J Cancer. 1993;67(2):284\u201389. https:\/\/doi.org\/10.1038\/bjc.1993.54.","journal-title":"Br J Cancer"},{"issue":"6","key":"812_CR105","doi-asserted-by":"publisher","first-page":"706","DOI":"10.3390\/pharmaceutics17060706","volume":"17","author":"L Ding","year":"2025","unstructured":"Ding L, Kshirsagar P, Agrawal P, Murry DJ. Crossing the blood\u2013brain barrier: innovations in receptor- and transporter-mediated transcytosis strategies. Pharmaceutics. 2025;17(6):706. https:\/\/doi.org\/10.3390\/pharmaceutics17060706.","journal-title":"Pharmaceutics"},{"issue":"1","key":"812_CR106","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1111\/tra.12533","volume":"19","author":"KYY Fung","year":"2018","unstructured":"Fung KYY, Fairn GD, Lee WL. Transcellular vesicular transport in epithelial and endothelial cells: challenges and opportunities. Traffic (Cph, Den). 2018;19(1):5\u201318. https:\/\/doi.org\/10.1111\/tra.12533.","journal-title":"Traffic (Cph, Den)"},{"key":"812_CR107","doi-asserted-by":"publisher","first-page":"101665","DOI":"10.1016\/j.pneurobio.2019.101665","volume":"181","author":"KB Johnsen","year":"2019","unstructured":"Johnsen KB, Burkhart A, Thomsen LB, Andresen TL, Moos T. Targeting the transferrin receptor for brain drug delivery. Prog Neurobiol. 2019;181:101665. https:\/\/doi.org\/10.1016\/j.pneurobio.2019.101665.","journal-title":"Prog Neurobiol"},{"issue":"5440","key":"812_CR108","doi-asserted-by":"publisher","first-page":"779","DOI":"10.1126\/science.286.5440.779","volume":"286","author":"CM Lawrence","year":"1999","unstructured":"Lawrence CM, Ray S, Babyonyshev M, Galluser R, Borhani DW, Harrison SC. Crystal structure of the ectodomain of human transferrin receptor. Sci (New Y, N.Y.). 1999;286(5440):779\u201382. https:\/\/doi.org\/10.1126\/science.286.5440.779.","journal-title":"Sci (New Y, N.Y.)"},{"issue":"2","key":"812_CR109","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1002\/j.1460-2075.1987.tb04758.x","volume":"6","author":"SQ Jing","year":"1987","unstructured":"Jing SQ, Trowbridge IS. Identification of the intermolecular disulfide bonds of the human transferrin receptor and its lipid-attachment site. Embo J. 1987;6(2):327\u201331. https:\/\/doi.org\/10.1002\/j.1460-2075.1987.tb04758.x.","journal-title":"Embo J"},{"issue":"4854","key":"812_CR110","doi-asserted-by":"publisher","first-page":"924","DOI":"10.1126\/science.2452485","volume":"240","author":"JL Casey","year":"1988","unstructured":"Casey JL, Hentze MW, Koeller DM, Caughman SW, Rouault TA, Klausner RD, et al. Iron-responsive elements: regulatory RNA sequences that control mRNA levels and translation. Sci (New Y, N.Y.). 1988;240(4854):924\u201328. https:\/\/doi.org\/10.1126\/science.2452485.","journal-title":"Sci (New Y, N.Y.)"},{"issue":"4833","key":"812_CR111","doi-asserted-by":"publisher","first-page":"1570","DOI":"10.1126\/science.3685996","volume":"238","author":"MW Hentze","year":"1987","unstructured":"Hentze MW, Caughman SW, Rouault TA, Barriocanal JG, Dancis A, Harford JB, et al. Identification of the iron-responsive element for the translational regulation of human ferritin mRNA. Sci (New Y, N.Y.). 1987;238(4833):1570\u201373. https:\/\/doi.org\/10.1126\/science.3685996.","journal-title":"Sci (New Y, N.Y.)"},{"issue":"17","key":"812_CR112","doi-asserted-by":"publisher","first-page":"12699","DOI":"10.1016\/S0021-9258(18)31444-3","volume":"268","author":"CR Bhasker","year":"1993","unstructured":"Bhasker CR, Burgiel G, Neupert B, Emery-Goodman A, K\u00fchn LC, May BK. The putative iron-responsive element in the human erythroid 5-aminolevulinate synthase mRNA mediates translational control. J Biol Chem. 1993;268(17):12699\u2013705. https:\/\/doi.org\/10.1016\/S0021-9258(18)31444-3.","journal-title":"J Biol Chem"},{"issue":"13","key":"812_CR113","doi-asserted-by":"publisher","first-page":"4638","DOI":"10.1128\/MCB.22.13.4638-4651.2002","volume":"22","author":"J Wang","year":"2002","unstructured":"Wang J, Pantopoulos K. Conditional derepression of ferritin synthesis in cells expressing a constitutive IRP1 mutant. Mol Cell Biol. 2002;22(13):4638\u201351. https:\/\/doi.org\/10.1128\/MCB.22.13.4638-4651.2002.","journal-title":"Mol Cell Biol"},{"issue":"9","key":"812_CR114","doi-asserted-by":"publisher","first-page":"4924","DOI":"10.1073\/pnas.95.9.4924","volume":"95","author":"K Iwai","year":"1998","unstructured":"Iwai K, Drake SK, Wehr NB, Weissman AM, LaVaute T, Minato N, et al. Iron-dependent oxidation, ubiquitination, and degradation of iron regulatory protein 2: implications for degradation of oxidized proteins. Proc Natl Acad Sci USA. 1998;95(9):4924\u201328. https:\/\/doi.org\/10.1073\/pnas.95.9.4924.","journal-title":"Proc Natl Acad Sci USA"},{"issue":"28","key":"812_CR115","doi-asserted-by":"publisher","first-page":"16529","DOI":"10.1074\/jbc.270.28.16529","volume":"270","author":"B Guo","year":"1995","unstructured":"Guo B, Brown FM, Phillips JD, Yu Y, Leibold EA. Characterization and expression of iron regulatory protein 2 (IRP2). Presence of multiple IRP2 transcripts regulated by intracellular iron levels. J Biol Chem. 1995;270(28):16529\u201335. https:\/\/doi.org\/10.1074\/jbc.270.28.16529.","journal-title":"J Biol Chem"},{"issue":"30","key":"812_CR116","doi-asserted-by":"publisher","first-page":"20826","DOI":"10.1074\/jbc.274.30.20826","volume":"274","author":"H Kawabata","year":"1999","unstructured":"Kawabata H, Yang R, Hirama T, Vuong PT, Kawano S, Gombart AF, et al. Molecular cloning of transferrin receptor 2. A new member of the transferrin receptor-like family. J Biol Chem. 1999;274(30):20826\u201332. https:\/\/doi.org\/10.1074\/jbc.274.30.20826.","journal-title":"J Biol Chem"},{"issue":"40","key":"812_CR117","doi-asserted-by":"publisher","first-page":"13978","DOI":"10.1021\/bi9812064","volume":"37","author":"PD Jeffrey","year":"1998","unstructured":"Jeffrey PD, Bewley MC, MacGillivray RTA, Mason AB, Woodworth RC, Baker EN. Ligand-induced conformational change in Transferrins: crystal structure of the open form of the N-Terminal half-molecule of human transferrin. Biochemistry. 1998;37(40):13978\u201386. https:\/\/doi.org\/10.1021\/bi9812064.","journal-title":"Biochemistry"},{"issue":"2","key":"812_CR118","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1042\/bj2190505","volume":"219","author":"SP Young","year":"1984","unstructured":"Young SP, Bomford A, Williams R. The effect of the iron saturation of transferrin on its binding and uptake by rabbit reticulocytes. The Biochemical J. 1984;219(2):505\u201310. https:\/\/doi.org\/10.1042\/bj2190505.","journal-title":"The Biochemical J"},{"issue":"11","key":"812_CR119","doi-asserted-by":"publisher","first-page":"1439","DOI":"10.1016\/j.addr.2003.07.004","volume":"55","author":"A Widera","year":"2003","unstructured":"Widera A, Norouziyan F, Shen W-C. Mechanisms of TfR-mediated transcytosis and sorting in epithelial cells and applications toward drug delivery. Adv Drug Deliv Rev. 2003;55(11):1439\u201366. https:\/\/doi.org\/10.1016\/j.addr.2003.07.004.","journal-title":"Adv Drug Deliv Rev"},{"issue":"6","key":"812_CR120","first-page":"387","volume":"2","author":"RG Parton","year":"1991","unstructured":"Parton RG. Endocytosis in polarized cells. Semin Cell Biol. 1991;2(6):387\u201395.","journal-title":"Semin Cell Biol"},{"issue":"2","key":"812_CR121","doi-asserted-by":"publisher","first-page":"605","DOI":"10.1128\/MCB.26.2.605-616.2006","volume":"26","author":"AJM Roebroek","year":"2006","unstructured":"Roebroek AJM, Reekmans S, Lauwers A, Feyaerts N, Smeijers L, Hartmann D. Mutant Lrp1 knock-in mice generated by recombinase-mediated cassette exchange reveal differential importance of the NPXY motifs in the intracellular domain of LRP1 for normal fetal development. Mol Cell Biol. 2006;26(2):605\u201316. https:\/\/doi.org\/10.1128\/MCB.26.2.605-616.2006.","journal-title":"Mol Cell Biol"},{"issue":"1","key":"812_CR122","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1007\/s00018-009-0171-7","volume":"67","author":"SM Reekmans","year":"2010","unstructured":"Reekmans SM, Pflanzner T, Gordts PLSM, Isbert S, Zimmermann P, Annaert W, et al. Inactivation of the proximal NPXY motif impairs early steps in LRP1 biosynthesis. Cell Mol Life Sci. 2010;67(1):135\u201345. https:\/\/doi.org\/10.1007\/s00018-009-0171-7.","journal-title":"Cell. Mol. Life Sci"},{"issue":"1","key":"812_CR123","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1146\/annurev.biochem.74.082803.133354","volume":"74","author":"H Jeon","year":"2005","unstructured":"Jeon H, Blacklow SC. Structure and physiologic function of the low-density lipoprotein receptor. Annu. Rev. Biochem. 2005;74(1):535\u201362. https:\/\/doi.org\/10.1146\/annurev.biochem.74.082803.133354.","journal-title":"Annu. Rev. Biochem"},{"issue":"19\u201320","key":"812_CR124","doi-asserted-by":"publisher","first-page":"2461","DOI":"10.1007\/s00018-004-4090-3","volume":"61","author":"J Gent","year":"2004","unstructured":"Gent J, Braakman I. Low-density lipoprotein receptor structure and folding. CMLS, Cell Mol Life Sci. 2004;61(19\u201320):2461\u201370. https:\/\/doi.org\/10.1007\/s00018-004-4090-3.","journal-title":"CMLS, Cell. Mol. Life Sci"},{"issue":"3","key":"812_CR125","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1097\/MOL.0b013e32832d3a10","volume":"20","author":"J Herz","year":"2009","unstructured":"Herz J. Apolipoprotein E receptors in the nervous system. Curr Opin Lipidol. 2009;20(3):190\u201396. https:\/\/doi.org\/10.1097\/MOL.0b013e32832d3a10.","journal-title":"Curr Opin Lipidol"},{"issue":"4959","key":"812_CR126","doi-asserted-by":"publisher","first-page":"1122","DOI":"10.1126\/science.2111583","volume":"248","author":"FS Esch","year":"1990","unstructured":"Esch FS, Keim PS, Beattie EC, Blacher RW, Culwell AR, Oltersdorf T, et al. Cleavage of amyloid \u03b2 peptide during constitutive processing of its precursor. Sci (New Y, N.Y.). 1990;248(4959):1122\u201324. https:\/\/doi.org\/10.1126\/science.2111583.","journal-title":"Sci (New Y, N.Y.)"},{"issue":"7","key":"812_CR127","doi-asserted-by":"publisher","first-page":"3922","DOI":"10.1073\/pnas.96.7.3922","volume":"96","author":"S Lammich","year":"1999","unstructured":"Lammich S, Kojro E, Postina R, Gilbert S, Pfeiffer R, Jasionowski M, et al. Constitutive and regulated \u03b1-secretase cleavage of Alzheimer\u2019s amyloid precursor protein by a disintegrin metalloprotease. Proc Natl Acad Sci USA. 1999;96(7):3922\u201327. https:\/\/doi.org\/10.1073\/pnas.96.7.3922.","journal-title":"Proc Natl Acad Sci USA"},{"key":"812_CR128","first-page":"197","volume":"95","author":"JN Octave","year":"1995","unstructured":"Octave JN. The amyloid peptide precursor in Alzheimer\u2019s disease. Acta Neurologica Belgica. 1995;95:197\u2013209.","journal-title":"Acta Neurologica Belgica"},{"issue":"11","key":"812_CR129","doi-asserted-by":"publisher","first-page":"2355","DOI":"10.4103\/1673-5374.335829","volume":"17","author":"Y-L Zhang","year":"2022","unstructured":"Zhang Y-L, Wang J, Zhang Z-N, Su Q, Guo J-H. The relationship between amyloid-beta and brain capillary endothelial cells in Alzheimer\u2019s disease. Neural Regen Res. 2022;17(11):2355\u201363. https:\/\/doi.org\/10.4103\/1673-5374.335829.","journal-title":"Neural Regen Res"},{"issue":"5440","key":"812_CR130","doi-asserted-by":"publisher","first-page":"735","DOI":"10.1126\/science.286.5440.735","volume":"286","author":"R Vassar","year":"1999","unstructured":"Vassar R, Bennett BD, Babu-Khan S, Kahn S, Mendiaz EA, Denis P, et al. \u03b2-secretase cleavage of Alzheimer\u2019s amyloid precursor protein by the transmembrane aspartic protease BACE. Sci (New Y, N.Y.). 1999;286(5440):735\u201341. https:\/\/doi.org\/10.1126\/science.286.5440.735.","journal-title":"Sci (New Y, N.Y.)"},{"issue":"3","key":"812_CR131","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1016\/S1474-4422(11)70013-8","volume":"10","author":"DJ Bonda","year":"2011","unstructured":"Bonda DJ, Lee H-G, Camins A, Pall\u00e0s M, Casadesus G, Smith MA, et al. The sirtuin pathway in ageing and Alzheimer disease: mechanistic and therapeutic considerations. Lancet Neurol. 2011;10(3):275\u201379. https:\/\/doi.org\/10.1016\/S1474-4422(11)70013-8.","journal-title":"The Lancet Neurol"},{"issue":"8","key":"812_CR132","doi-asserted-by":"publisher","first-page":"864","DOI":"10.1038\/nm0896-864","volume":"2","author":"D Scheuner","year":"1996","unstructured":"Scheuner D, Eckman C, Jensen M, Song X, Citron M, Suzuki N, et al. Secreted amyloid \u03b2\u2013protein similar to that in the senile plaques of Alzheimer\u2019s disease is increased in vivo by the presenilin 1 and 2 and APP mutations linked to familial Alzheimer\u2019s disease. Nat Med. 1996;2(8):864\u201370. https:\/\/doi.org\/10.1038\/nm0896-864.","journal-title":"Nat Med"},{"issue":"11","key":"812_CR133","doi-asserted-by":"publisher","first-page":"292","DOI":"10.15698\/cst2018.11.162","volume":"2","author":"H Steiner","year":"2018","unstructured":"Steiner H, Fukumori A, Tagami S, Okochi M. Making the final cut: pathogenic amyloid-\u03b2 peptide generation by \u03b3-secretase. CST. 2018;2(11):292\u2013310. https:\/\/doi.org\/10.15698\/cst2018.11.162.","journal-title":"CST"},{"issue":"1","key":"812_CR134","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1186\/s13195-020-00746-8","volume":"13","author":"Q Su","year":"2021","unstructured":"Su Q, Li T, He P-F, Lu X-C, Yu Q, Gao Q-C, et al. Trichostatin a ameliorates Alzheimer\u2019s disease-related pathology and cognitive deficits by increasing albumin expression and A\u03b2 clearance in APP\/PS1 mice. Alz Res Ther. 2021;13(1):7. https:\/\/doi.org\/10.1186\/s13195-020-00746-8.","journal-title":"Alz Res Ther"},{"issue":"1","key":"812_CR135","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1172\/JCI81108","volume":"126","author":"SE Storck","year":"2016","unstructured":"Storck SE, Meister S, Nahrath J, Mei\u00dfner JN, Schubert N, Di Spiezio A, et al. Endothelial LRP1 transports amyloid-\u03b21\u201342 across the blood-brain barrier. J Clin Investigation. 2016;126(1):123\u201336. https:\/\/doi.org\/10.1172\/JCI81108.","journal-title":"J Clin Investigation"},{"issue":"7","key":"812_CR136","doi-asserted-by":"publisher","first-page":"978","DOI":"10.1038\/nn.4025","volume":"18","author":"Z Zhao","year":"2015","unstructured":"Zhao Z, Sagare AP, Ma Q, Halliday MR, Kong P, Kisler K, et al. Central role for PICALM in amyloid-\u03b2 blood-brain barrier transcytosis and clearance. Nat. Neurosci. 2015;18(7):978\u201387. https:\/\/doi.org\/10.1038\/nn.4025.","journal-title":"Nat. Neurosci"},{"issue":"1","key":"812_CR137","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1186\/s12987-018-0113-6","volume":"15","author":"SB Hladky","year":"2018","unstructured":"Hladky SB, Barrand MA. Elimination of substances from the brain parenchyma: efflux via perivascular pathways and via the blood\u2013brain barrier. Fluids Barriers CNS. 2018;15(1):30. https:\/\/doi.org\/10.1186\/s12987-018-0113-6.","journal-title":"Fluids Barriers CNS"},{"issue":"24","key":"812_CR138","doi-asserted-by":"publisher","first-page":"3994","DOI":"10.3390\/cells11243994","volume":"11","author":"K Ando","year":"2022","unstructured":"Ando K, Nagaraj S, K\u00fc\u00e7\u00fckali F, de Fisenne M-A, Kosa A-C, Doeraene E, et al. PICALM and Alzheimer\u2019s disease: an update and perspectives. Cells. 2022;11(24):3994. https:\/\/doi.org\/10.3390\/cells11243994.","journal-title":"Cells"},{"issue":"3","key":"812_CR139","doi-asserted-by":"publisher","first-page":"1272","DOI":"10.1172\/JCI124853","volume":"129","author":"M Tachibana","year":"2019","unstructured":"Tachibana M, Holm M-L, Liu C-C, Shinohara M, Aikawa T, Oue H, et al. APOE4-mediated amyloid-\u03b2 pathology depends on its neuronal receptor LRP1. J Clin Investigation. 2019;129(3):1272\u201377. https:\/\/doi.org\/10.1172\/JCI124853.","journal-title":"J Clin Investigation"},{"issue":"4","key":"812_CR140","doi-asserted-by":"publisher","first-page":"1299","DOI":"10.1093\/brain\/awac495","volume":"146","author":"H Wei","year":"2023","unstructured":"Wei H, Jiang H, Zhou Y, Xiao X, Zhou C, Ji X. Vascular endothelial cells: a fundamental approach for brain waste clearance. Brain: J Neurol. 2023;146(4):1299\u2013315. https:\/\/doi.org\/10.1093\/brain\/awac495.","journal-title":"Brain: J Neurol"},{"key":"812_CR141","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1016\/j.brainres.2010.08.034","volume":"1358","author":"HC Wijesuriya","year":"2010","unstructured":"Wijesuriya HC, Bullock JY, Faull RLM, Hladky SB, Barrand MA. ABC efflux transporters in brain vasculature of Alzheimer\u2019s subjects. Brain Res. 2010;1358:228\u201338. https:\/\/doi.org\/10.1016\/j.brainres.2010.08.034.","journal-title":"Brain Res"},{"issue":"1","key":"812_CR142","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1016\/j.nbd.2007.12.005","volume":"30","author":"B Nazer","year":"2008","unstructured":"Nazer B, Hong S, Selkoe DJ. LRP promotes endocytosis and degradation, but not transcytosis, of the amyloid-\u03b2 peptide in a blood\u2013brain barrier in vitro model. Neurobiol Disease. 2008;30(1):94\u2013102. https:\/\/doi.org\/10.1016\/j.nbd.2007.12.005.","journal-title":"Neurobiol Disease"},{"issue":"5","key":"812_CR143","doi-asserted-by":"publisher","first-page":"1356","DOI":"10.1111\/j.1471-4159.2010.06708.x","volume":"113","author":"S Ito","year":"2010","unstructured":"Ito S, Ueno T, Ohtsuki S, Terasaki T. Lack of brain-to-blood efflux transport activity of low-density lipoprotein receptor-related protein-1 (LRP-1) for amyloid-\u03b2 peptide(1\u201340) in mouse: involvement of an LRP-1-independent pathway. J Neurochem. 2010;113(5):1356\u201363. https:\/\/doi.org\/10.1111\/j.1471-4159.2010.06708.x.","journal-title":"J Neurochem"},{"key":"812_CR144","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/j.brainres.2014.10.047","volume":"1594","author":"P Candela","year":"2015","unstructured":"Candela P, Saint-Pol J, Kuntz M, Boucau M-C, Lamartiniere Y, Gosselet F, et al. In vitro discrimination of the role of LRP1 at the BBB cellular level: focus on brain capillary endothelial cells and brain pericytes. Brain Res. 2015;1594:15\u201326. https:\/\/doi.org\/10.1016\/j.brainres.2014.10.047.","journal-title":"Brain Res"},{"key":"812_CR145","doi-asserted-by":"publisher","unstructured":"Pflanzner T, Janko MC, Andr\u00e9-Dohmen B, Reuss S, Weggen S, Roebroek AJM, et al. LRP1 mediates bidirectional transcytosis of amyloid-\u03b2 across the blood-brain barrier. Neurobiol Aging. 2011;32(12):.e2323.1\u20132323.11. https:\/\/doi.org\/10.1016\/j.neurobiolaging.2010.05.025.","DOI":"10.1016\/j.neurobiolaging.2010.05.025"},{"issue":"7","key":"812_CR146","doi-asserted-by":"publisher","first-page":"723","DOI":"10.1007\/s00431-008-0740-z","volume":"167","author":"L Corbeel","year":"2008","unstructured":"Corbeel L, Freson K. Rab proteins and Rab-associated proteins: major actors in the mechanism of protein-trafficking disorders. Eur J Pediatr. 2008;167(7):723\u201329. https:\/\/doi.org\/10.1007\/s00431-008-0740-z.","journal-title":"Eur J Pediatr"},{"key":"812_CR147","doi-asserted-by":"publisher","first-page":"139828","DOI":"10.1016\/j.ijbiomac.2025.139828","volume":"296","author":"ZA Parray","year":"2025","unstructured":"Parray ZA. A review on evolution, structural characteristics, interactions, and regulation of the membrane transport protein: the family of Rab proteins. Int J Biol Macromolecules. 2025;296:139828. https:\/\/doi.org\/10.1016\/j.ijbiomac.2025.139828.","journal-title":"Int J Biol Macromolecules"},{"issue":"5545","key":"812_CR148","doi-asserted-by":"publisher","first-page":"1299","DOI":"10.1126\/science.1062023","volume":"294","author":"IR Vetter","year":"2001","unstructured":"Vetter IR, Wittinghofer A. The guanine nucleotide-binding switch in three dimensions. Sci (New Y, N.Y.). 2001;294(5545):1299\u2013304. https:\/\/doi.org\/10.1126\/science.1062023.","journal-title":"Sci (New Y, N.Y.)"},{"issue":"8","key":"812_CR149","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1038\/nrm2728","volume":"10","author":"H Stenmark","year":"2009","unstructured":"Stenmark H. Rab GTPases as coordinators of vesicle traffic. Nat Rev Mol Cell Biol. 2009;10(8):513\u201325. https:\/\/doi.org\/10.1038\/nrm2728.","journal-title":"Nat Rev Mol Cell Biol"},{"issue":"1\u20132","key":"812_CR150","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1016\/S0167-4889(98)00050-0","volume":"1404","author":"O Martinez","year":"1998","unstructured":"Martinez O, Goud B. Rab proteins. Biochim et Biophys Acta (BBA) - Mol Cell Res. 1998;1404(1\u20132):101\u201312. https:\/\/doi.org\/10.1016\/S0167-4889(98)00050-0.","journal-title":"Biochim et Biophys Acta (BBA) - Mol Cell Res"},{"issue":"3","key":"812_CR151","doi-asserted-by":"publisher","first-page":"246","DOI":"10.1016\/S1474-4422(24)00476-9","volume":"24","author":"JH Pedder","year":"2025","unstructured":"Pedder JH, Sonabend AM, Cearns MD, Michael BD, Zakaria R, Heimberger AB, et al. Crossing the blood\u2013brain barrier: emerging therapeutic strategies for neurological disease. The Lancet Neurol. 2025;24(3):246\u201360. https:\/\/doi.org\/10.1016\/S1474-4422(24)00476-9.","journal-title":"The Lancet Neurol"},{"issue":"6","key":"812_CR152","doi-asserted-by":"publisher","first-page":"1517","DOI":"10.1016\/j.celrep.2016.01.027","volume":"14","author":"K Smurova","year":"2016","unstructured":"Smurova K, Podbilewicz B. RAB-5- and DYNAMIN-1-Mediated endocytosis of EFF-1 Fusogen controls cell-cell fusion. Cell Rep. 2016;14(6):1517\u201327. https:\/\/doi.org\/10.1016\/j.celrep.2016.01.027.","journal-title":"Cell Rep"},{"issue":"6","key":"812_CR153","doi-asserted-by":"publisher","first-page":"378","DOI":"10.2183\/pjab.93.023","volume":"93","author":"S Arakawa","year":"2017","unstructured":"Arakawa S, Honda S, Yamaguchi H, Shimizu S. Molecular mechanisms and physiological roles of Atg5\/Atg7-independent alternative autophagy. Proc The Jpn Acad. Ser. B: Phys Biol Sci. 2017;93(6):378\u201385. https:\/\/doi.org\/10.2183\/pjab.93.023.","journal-title":"Proc The Jpn Acad. Ser. B: Phys Biol Sci"},{"issue":"1","key":"812_CR154","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1006\/excr.2000.4947","volume":"259","author":"B Schlierf","year":"2000","unstructured":"Schlierf B, Fey GH, Hauber J, Hocke GM, Rosorius O. Rab11b is essential for recycling of transferrin to the plasma membrane. Exp Cell Res. 2000;259(1):257\u201365. https:\/\/doi.org\/10.1006\/excr.2000.4947.","journal-title":"Exp Cell Res"},{"key":"812_CR155","doi-asserted-by":"publisher","unstructured":"Shi M-M, Shi C-H, Xu Y-M. Rab GTPases: the key players in the Molecular pathway of Parkinson\u2019s disease. Front. Cell. Neurosci. 2017;11(81). https:\/\/doi.org\/10.3389\/fncel.2017.00081.","DOI":"10.3389\/fncel.2017.00081"},{"issue":"3","key":"812_CR156","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1080\/21541248.2019.1680066","volume":"12","author":"R Haley","year":"2021","unstructured":"Haley R, Zhou Z. The small GTPase RAB-35 facilitates the initiation of phagosome maturation and acts as a robustness factor for apoptotic cell clearance. Small GTPases. 2021;12(3):188\u2013201. https:\/\/doi.org\/10.1080\/21541248.2019.1680066.","journal-title":"Small GTPases"},{"key":"812_CR157","doi-asserted-by":"publisher","unstructured":"Kyrtsos CR, Baras JS. Modeling the role of the glymphatic pathway and cerebral blood vessel properties in Alzheimer\u2019s disease pathogenesis. PLoS One. 2015;10(10):e0139574. https:\/\/doi.org\/10.1371\/journal.pone.0139574.","DOI":"10.1371\/journal.pone.0139574"},{"key":"812_CR158","doi-asserted-by":"publisher","first-page":"665803","DOI":"10.3389\/fnana.2021.665803","volume":"15","author":"J Kaur","year":"2021","unstructured":"Kaur J, Fahmy LM, Davoodi-Bojd E, Zhang L, Ding G, Hu J, et al. Waste clearance in the brain. Front Neuroanat. 2021;15:665803. https:\/\/doi.org\/10.3389\/fnana.2021.665803.","journal-title":"Front Neuroanat"},{"issue":"12","key":"812_CR159","doi-asserted-by":"publisher","first-page":"1489","DOI":"10.1172\/JCI10498","volume":"106","author":"M Shibata","year":"2000","unstructured":"Shibata M, Yamada S, Kumar SR, Calero M, Bading J, Frangione B, et al. Clearance of Alzheimer\u2019s amyloid-\u03b21-40 peptide from brain by LDL receptor\u2013related protein-1 at the blood-brain barrier. J. Clin. Invest. 2000;106(12):1489\u201399. https:\/\/doi.org\/10.1172\/JCI10498.","journal-title":"J. Clin. Invest"},{"issue":"1","key":"812_CR160","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1016\/0006-8993(87)90236-8","volume":"420","author":"KR Duffy","year":"1987","unstructured":"Duffy KR, Pardridge WM. Blood-brain barrier transcytosis of insulin in developing rabbits. Brain Res. 1987;420(1):32\u201338. https:\/\/doi.org\/10.1016\/0006-8993(87)90236-8.","journal-title":"Brain Res"},{"issue":"6","key":"812_CR161","doi-asserted-by":"publisher","first-page":"881","DOI":"10.1016\/0361-9230(88)90021-4","volume":"21","author":"WA Banks","year":"1988","unstructured":"Banks WA, Kastin AJ, Fasold MB, Barrera CM, Augereau G. Studies of the slow bidirectional transport of iron and transferrin across the blood-brain barrier. Brain Res Bull. 1988;21(6):881\u201385. https:\/\/doi.org\/10.1016\/0361-9230(88)90021-4.","journal-title":"Brain Res Bull"},{"issue":"45","key":"812_CR162","doi-asserted-by":"publisher","first-page":"17553","DOI":"10.1523\/JNEUROSCI.3258-13.2013","volume":"33","author":"MK Lehtinen","year":"2013","unstructured":"Lehtinen MK, Bjornsson CS, Dymecki SM, Gilbertson RJ, Holtzman DM, Monuki ES. The choroid plexus and cerebrospinal fluid: emerging roles in development, disease, and therapy. J Neurosci. 2013;33(45):17553\u201359. https:\/\/doi.org\/10.1523\/JNEUROSCI.3258-13.2013.","journal-title":"J Neurosci"},{"issue":"3","key":"812_CR163","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1007\/s00401-018-1812-4","volume":"135","author":"NJ Abbott","year":"2018","unstructured":"Abbott NJ, Pizzo ME, Preston JE, Janigro D, Thorne RG. The role of brain barriers in fluid movement in the CNS: is there a \u2018glymphatic\u2019 system? Acta Neuropathologica. 2018;135(3):387\u2013407. https:\/\/doi.org\/10.1007\/s00401-018-1812-4.","journal-title":"Acta Neuropathologica"},{"issue":"1","key":"812_CR164","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1186\/2045-8118-11-26","volume":"11","author":"SB Hladky","year":"2014","unstructured":"Hladky SB, Barrand MA. Mechanisms of fluid movement into, through and out of the brain: evaluation of the evidence. Fluids Barriers CNS. 2014;11(1):26. https:\/\/doi.org\/10.1186\/2045-8118-11-26.","journal-title":"Fluids Barriers CNS"},{"issue":"9","key":"812_CR165","doi-asserted-by":"publisher","first-page":"1450","DOI":"10.3390\/ijms17091450","volume":"17","author":"P Proia","year":"2016","unstructured":"Proia P, Di Liegro CM, Schiera G, Fricano A, Di Liegro I. Lactate as a metabolite and a regulator in the central nervous system. IJMS. 2016;17(9):1450. https:\/\/doi.org\/10.3390\/ijms17091450.","journal-title":"IJMS"},{"issue":"4","key":"812_CR166","doi-asserted-by":"publisher","first-page":"656","DOI":"10.2174\/138920111795164020","volume":"12","author":"AMS Hartz","year":"2011","unstructured":"Hartz AMS, Bauer B. ABC transporters in the CNS \u2013 an inventory. CPB. 2011;12(4):656\u201373. https:\/\/doi.org\/10.2174\/138920111795164020.","journal-title":"CPB"},{"issue":"4","key":"812_CR167","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1016\/0092-8674(94)90212-7","volume":"77","author":"AH Schinkel","year":"1994","unstructured":"Schinkel AH, Smit JJM, van Tellingen O, Beijnen JH, Wagenaar E, van Deemter L, et al. Disruption of the mouse mdr1a P-glycoprotein gene leads to a deficiency in the blood-brain barrier and to increased sensitivity to drugs. Cell. 1994;77(4):491\u2013502. https:\/\/doi.org\/10.1016\/0092-8674(94)90212-7.","journal-title":"Cell"},{"issue":"2","key":"812_CR168","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1124\/mol.104.003319","volume":"67","author":"MF Olive","year":"2005","unstructured":"Olive MF, Mcgeehan AJ, Kinder JR, McMahon T, Hodge CW, Janak PH, et al. The mGlur5 antagonist 6-methyl-2-(phenylethynyl)pyridine decreases ethanol consumption via a protein kinase C\u03f5-dependent mechanism. Mol Pharmacol. 2005;67(2):349\u201355. https:\/\/doi.org\/10.1124\/mol.104.003319.","journal-title":"Mol Pharmacol"},{"issue":"37","key":"812_CR169","doi-asserted-by":"publisher","first-page":"23629","DOI":"10.1074\/jbc.273.37.23629","volume":"273","author":"Y Kanai","year":"1998","unstructured":"Kanai Y, Segawa H, Miyamoto K-I, Uchino H, Takeda E, Endou H. Expression cloning and characterization of a transporter for large neutral amino acids activated by the heavy chain of 4F2 antigen (CD98). J Biol Chem. 1998;273(37):23629\u201332. https:\/\/doi.org\/10.1074\/jbc.273.37.23629.","journal-title":"J Biol Chem"},{"key":"812_CR170","doi-asserted-by":"publisher","unstructured":"Gerhart DZ, Enerson BE, Zhdankina OY, Leino RL, Drewes LR. Expression of monocarboxylate transporter MCT1 by brain endothelium and glia in adult and suckling rats. Am J Physiol-Endoc M. 1997;273(1):E207\u201313. https:\/\/doi.org\/10.1152\/ajpendo.1997.273.1.E207.","DOI":"10.1152\/ajpendo.1997.273.1.E207"},{"issue":"12","key":"812_CR171","doi-asserted-by":"publisher","first-page":"4002","DOI":"10.1172\/JCI36663","volume":"118","author":"R Deane","year":"2008","unstructured":"Deane R, Sagare A, Hamm K, Parisi M, Lane S, Finn MB, et al. apoE isoform\u2013specific disruption of amyloid \u03b2 peptide clearance from mouse brain. J. Clin. Invest. 2008;118(12):4002\u201313. https:\/\/doi.org\/10.1172\/JCI36663.","journal-title":"J. Clin. Invest"},{"issue":"1","key":"812_CR172","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1038\/jcbfm.2015.44","volume":"36","author":"MR Halliday","year":"2016","unstructured":"Halliday MR, Rege SV, Ma Q, Zhao Z, Miller CA, Winkler EA, et al. Accelerated pericyte degeneration and blood\u2013brain barrier breakdown in apolipoprotein E4 carriers with Alzheimer\u2019s disease. J Cereb Blood Flow Metab. 2016;36(1):216\u201327. https:\/\/doi.org\/10.1038\/jcbfm.2015.44.","journal-title":"J Cereb Blood Flow Metab"},{"key":"812_CR173","first-page":"59","volume":"65","author":"F Li","year":"2018","unstructured":"Li F, et al. Upregulation of lipoprotein receptors on brain endothelial cells and neurons in the early phase of ischemic stroke in mice. J Med Dent Sci. 2018;65:59\u201371. https:\/\/www.jstage.jst.go.jp\/article\/jmds\/65\/2\/65_650203\/_article\/-char\/ja\/.","journal-title":"J Med Dent Sci"},{"issue":"12","key":"812_CR174","doi-asserted-by":"publisher","first-page":"1584","DOI":"10.1038\/nm.3407","volume":"19","author":"B Obermeier","year":"2013","unstructured":"Obermeier B, Daneman R, Ransohoff RM. Development, maintenance and disruption of the blood-brain barrier. Nat Med. 2013;19(12):1584\u201396. https:\/\/doi.org\/10.1038\/nm.3407.","journal-title":"Nat Med"},{"issue":"11","key":"812_CR175","doi-asserted-by":"publisher","first-page":"1798","DOI":"10.1016\/j.freeradbiomed.2010.09.013","volume":"49","author":"JB Owen","year":"2010","unstructured":"Owen JB, Sultana R, Aluise CD, Erickson MA, Price TO, Bu G, et al. Oxidative modification to LDL receptor-related protein 1 in hippocampus from subjects with Alzheimer disease: implications for A\u03b2 accumulation in AD brain. Free Radical Biol Med. 2010;49(11):1798\u2013803. https:\/\/doi.org\/10.1016\/j.freeradbiomed.2010.09.013.","journal-title":"Free Radical Biol Med"},{"key":"812_CR176","doi-asserted-by":"publisher","unstructured":"Bates DO, Curry FE. Vascular endothelial growth factor increases microvascular permeability via a Ca(2+)-dependent pathway. Am J Physiol-Heart Circulatory Physiol. 1997;273(2):H687\u201394. https:\/\/doi.org\/10.1152\/ajpheart.1997.273.2.H687.","DOI":"10.1152\/ajpheart.1997.273.2.H687"},{"issue":"6","key":"812_CR177","doi-asserted-by":"publisher","first-page":"1977","DOI":"10.1073\/pnas.0808698106","volume":"106","author":"AT Argaw","year":"2009","unstructured":"Argaw AT, Gurfein BT, Zhang Y, Zameer A, John GR. VEGF-mediated disruption of endothelial CLN-5 promotes blood-brain barrier breakdown. Proc Natl Acad Sci USA. 2009;106(6):1977\u201382. https:\/\/doi.org\/10.1073\/pnas.0808698106.","journal-title":"Proc Natl Acad Sci USA"},{"issue":"13","key":"812_CR178","doi-asserted-by":"publisher","first-page":"3666","DOI":"10.1096\/fj.07-8329com","volume":"21","author":"G Schreibelt","year":"2007","unstructured":"Schreibelt G, Kooij G, Reijerkerk A, van Doorn R, Gringhuis SI, van der Pol S, et al. Reactive oxygen species alter brain endothelial tight junction dynamics via RhoA, PI3 kinase, and PKB signaling. The FASEB J. 2007;21(13):3666\u201376. https:\/\/doi.org\/10.1096\/fj.07-8329com.","journal-title":"The FASEB J"},{"issue":"2","key":"812_CR179","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1111\/j.1748-1716.1987.tb08057.x","volume":"129","author":"SP Olesen","year":"1987","unstructured":"Olesen SP. Free oxygen radicals decrease electrical resistance of microvascular endothelium in brain. Acta Physiologica Scandinavica. 1987;129(2):181\u201387. https:\/\/doi.org\/10.1111\/j.1748-1716.1987.tb08057.x.","journal-title":"Acta Physiologica Scandinavica"},{"issue":"1","key":"812_CR180","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1007\/BF01057957","volume":"20","author":"JL Wright","year":"1994","unstructured":"Wright JL, Merchant RE. Blood-brain barrier changes following intracerebral injection of human recombinant tumor necrosis factor-? in the rat. J Neuro-Oncol. 1994;20(1):17\u201325. https:\/\/doi.org\/10.1007\/BF01057957.","journal-title":"J Neuro-Oncol"},{"issue":"2","key":"812_CR181","doi-asserted-by":"publisher","first-page":"553","DOI":"10.4049\/jimmunol.163.2.553","volume":"163","author":"H Ozaki","year":"1999","unstructured":"Ozaki H, Ishii K, Horiuchi H, Arai H, Kawamoto T, Okawa K, et al. Cutting edge: combined treatment of TNF-\u03b1 and IFN-\u03b3 causes redistribution of junctional adhesion molecule in human endothelial cells. J Immunol. 1999;163(2):553\u201357. https:\/\/doi.org\/10.4049\/jimmunol.163.2.553.","journal-title":"J Immunol"},{"key":"812_CR182","doi-asserted-by":"publisher","unstructured":"W\u00f3jciak-Stothard B, Entwistle A, Garg R, Ridley AJ. Regulation of TNF-\u03b1-induced reorganization of the actin cytoskeleton and cell-cell junctions by Rho, Rac, and Cdc42 in human endothelial cells. J. Cell. Physiol. 1998;176(1):150\u201365. https:\/\/doi.org\/10.1002\/(SICI)1097-4652(199807)176:1%3C150::AID-JCP17%3E3.0.CO;2-B.","DOI":"10.1002\/(SICI)1097-4652(199807)176:1%3C150::AID-JCP17%3E3.0.CO;2-B"},{"issue":"38","key":"812_CR183","doi-asserted-by":"publisher","first-page":"9451","DOI":"10.1523\/JNEUROSCI.2674-08.2008","volume":"28","author":"BW McColl","year":"2008","unstructured":"McColl BW, Rothwell NJ, Allan SM. Systemic inflammation alters the kinetics of cerebrovascular tight junction disruption after experimental stroke in mice. J Neurosci. 2008;28(38):9451\u201362. https:\/\/doi.org\/10.1523\/JNEUROSCI.2674-08.2008.","journal-title":"J Neurosci"},{"issue":"4","key":"812_CR184","doi-asserted-by":"publisher","first-page":"697","DOI":"10.1038\/sj.jcbfm.9600375","volume":"27","author":"Y Yang","year":"2007","unstructured":"Yang Y, Estrada EY, Thompson JF, Liu W, Rosenberg GA. Matrix metalloproteinase-mediated disruption of tight junction proteins in cerebral vessels is reversed by synthetic matrix metalloproteinase inhibitor in focal ischemia in rat. J Cereb Blood Flow Metab. 2007;27(4):697\u2013709. https:\/\/doi.org\/10.1038\/sj.jcbfm.9600375.","journal-title":"J Cereb Blood Flow Metab"},{"key":"812_CR185","doi-asserted-by":"publisher","unstructured":"Gidday JM, Gasche YG, Copin J-C, Shah AR, Perez RS, Shapiro SD, et al. Leukocyte-derived matrix metalloproteinase-9 mediates blood-brain barrier breakdown and is proinflammatory after transient focal cerebral ischemia. Am J Physiol-Heart Circulatory Physiol. 2005;289(2):H558\u201368. https:\/\/doi.org\/10.1152\/ajpheart.01275.2004.","DOI":"10.1152\/ajpheart.01275.2004"},{"issue":"3","key":"812_CR186","doi-asserted-by":"publisher","first-page":"376","DOI":"10.1016\/j.nbd.2010.03.008","volume":"38","author":"R Jin","year":"2010","unstructured":"Jin R, Yang G, Li G. Molecular insights and therapeutic targets for blood\u2013brain barrier disruption in ischemic stroke: critical role of matrix metalloproteinases and tissue-type plasminogen activator. Neurobiol Disease. 2010;38(3):376\u201385. https:\/\/doi.org\/10.1016\/j.nbd.2010.03.008.","journal-title":"Neurobiol Disease"},{"issue":"1","key":"812_CR187","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1007\/s40520-024-02729-3","volume":"36","author":"F Nabizadeh","year":"2024","unstructured":"Nabizadeh F, Valizadeh P, Fallahi MS. Bile acid profile associated with CSF and PET biomarkers in Alzheimer\u2019s disease. Aging Clin Exp Res. 2024;36(1):62. https:\/\/doi.org\/10.1007\/s40520-024-02729-3.","journal-title":"Aging Clin Exp Res"},{"issue":"1","key":"812_CR188","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1007\/s12017-020-08625-z","volume":"23","author":"VF Monteiro-Cardoso","year":"2021","unstructured":"Monteiro-Cardoso VF, Corlian\u00f2 M, Singaraja RR. Bile acids: a communication channel in the gut-brain axis. NeuroMol Med. 2021;23(1):99\u2013117. https:\/\/doi.org\/10.1007\/s12017-020-08625-z.","journal-title":"NeuroMol Med"},{"key":"812_CR189","doi-asserted-by":"publisher","unstructured":"Coon BG, Timalsina S, Astone M, Zhuang ZW, Fang J, Han J, et al. A mitochondrial contribution to anti-inflammatory shear stress signaling in vascular endothelial cells. J Cell Biol. 2022;221(7). https:\/\/doi.org\/10.1083\/jcb.202109144.","DOI":"10.1083\/jcb.202109144"},{"key":"812_CR190","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1016\/j.nbd.2018.09.006","volume":"126","author":"SM Stamatovic","year":"2019","unstructured":"Stamatovic SM, Martinez-Revollar G, Hu A, Choi J, Keep RF, Andjelkovic AV. Decline in sirtuin-1 expression and activity plays a critical role in blood-brain barrier permeability in aging. Neurobiol Disease. 2019;126:105\u201316. https:\/\/doi.org\/10.1016\/j.nbd.2018.09.006.","journal-title":"Neurobiol Disease"},{"key":"812_CR191","doi-asserted-by":"publisher","unstructured":"Chen C-Y, Chao Y-M, Lin H-F, Chen C-J, Chen C-S, Yang J-L, et al. miR-195 reduces age-related blood\u2013brain barrier leakage caused by thrombospondin-1-mediated selective autophagy. Aging Cell. 2020;19(11):e13236. https:\/\/doi.org\/10.1111\/acel.13236.","DOI":"10.1111\/acel.13236"},{"key":"812_CR192","doi-asserted-by":"publisher","first-page":"146353","DOI":"10.1016\/j.brainres.2019.146353","volume":"1722","author":"S Guo","year":"2019","unstructured":"Guo S, Som AT, Arai K, Lo EH. Effects of angiotensin-II on brain endothelial cell permeability via PPARalpha regulation of para- and trans-cellular pathways. Brain Res. 2019;1722:146353. https:\/\/doi.org\/10.1016\/j.brainres.2019.146353.","journal-title":"Brain Res"},{"issue":"7816","key":"812_CR193","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1038\/s41586-020-2453-z","volume":"583","author":"AC Yang","year":"2020","unstructured":"Yang AC, Stevens MY, Chen MB, Lee DP, St\u00e4hli D, Gate D, et al. Physiological blood\u2013brain transport is impaired with age by a shift in transcytosis. Nature. 2020;583(7816):425\u201330. https:\/\/doi.org\/10.1038\/s41586-020-2453-z.","journal-title":"Nature"},{"issue":"2","key":"812_CR194","doi-asserted-by":"publisher","first-page":"901","DOI":"10.1007\/s11357-021-00350-0","volume":"43","author":"S Tarantini","year":"2021","unstructured":"Tarantini S, Balasubramanian P, Yabluchanskiy A, Ashpole NM, Logan S, Kiss T, et al. IGF1R signaling regulates astrocyte-mediated neurovascular coupling in mice: implications for brain aging. GeroScience. 2021;43(2):901\u201311. https:\/\/doi.org\/10.1007\/s11357-021-00350-0.","journal-title":"GeroScience"},{"issue":"8","key":"812_CR195","doi-asserted-by":"publisher","first-page":"1426","DOI":"10.3390\/antiox11081426","volume":"11","author":"T Heurtaux","year":"2022","unstructured":"Heurtaux T, Bouvier DS, Benani A, Helgueta Romero S, Frauenknecht KBM, Mittelbronn M, et al. Normal and pathological NRF2 signalling in the central nervous system. Antioxid (Basel, Switz). 2022;11(8):1426. https:\/\/doi.org\/10.3390\/antiox11081426.","journal-title":"Antioxid (Basel, Switz)"},{"issue":"11","key":"812_CR196","doi-asserted-by":"publisher","first-page":"692","DOI":"10.1038\/nri3908","volume":"15","author":"D Vestweber","year":"2015","unstructured":"Vestweber D. How leukocytes cross the vascular endothelium. Nat Rev Immunol. 2015;15(11):692\u2013704. https:\/\/doi.org\/10.1038\/nri3908.","journal-title":"Nat Rev Immunol"},{"issue":"2","key":"812_CR197","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1002\/JLB.2A0718-272RR","volume":"106","author":"W Liu","year":"2019","unstructured":"Liu W, Wang X, Wang S, Ba X, Xu T, Wang X, et al. RhoGDI2 positively regulates the Rho GTPases activation in response to the \u03b22 outside-in signaling in T cells adhesion and migration on ICAM-1. J Leukoc Biol. 2019;106(2):431\u201346. https:\/\/doi.org\/10.1002\/JLB.2A0718-272RR.","journal-title":"J Leukoc Biol"},{"issue":"1","key":"812_CR198","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1186\/1742-2094-8-102","volume":"8","author":"L Mestre","year":"2011","unstructured":"Mestre L, I\u00f1igo PM, Mecha M, Correa FG, Hernang\u00f3mez-Herrero M, Lor\u00eda F, et al. Anandamide inhibits Theiler\u2019s virus induced VCAM-1 in brain endothelial cells and reduces leukocyte transmigration in a model of blood brain barrier by activation of CB1receptors. J Neuroinflammation. 2011;8(1):102. https:\/\/doi.org\/10.1186\/1742-2094-8-102.","journal-title":"J Neuroinflammation"},{"issue":"1","key":"812_CR199","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1093\/brain\/awr298","volume":"135","author":"DME van Assema","year":"2012","unstructured":"van Assema DME, Lubberink M, Bauer M, van der Flier WM, Schuit RC, Windhorst AD, et al. Blood\u2013brain barrier P-glycoprotein function in Alzheimer\u2019s disease. Brain: J Neurol. 2012;135(1):181\u201389. https:\/\/doi.org\/10.1093\/brain\/awr298.","journal-title":"Brain: J Neurol"},{"issue":"11","key":"812_CR200","doi-asserted-by":"publisher","first-page":"1818","DOI":"10.1016\/j.neurobiolaging.2008.02.002","volume":"30","author":"AL Bartels","year":"2009","unstructured":"Bartels AL, Kortekaas R, Bart J, Willemsen ATM, de Klerk OL, de Vries JJ, et al. Blood\u2013brain barrier P-glycoprotein function decreases in specific brain regions with aging: a possible role in progressive neurodegeneration. Neurobiol Aging. 2009;30(11):1818\u201324. https:\/\/doi.org\/10.1016\/j.neurobiolaging.2008.02.002.","journal-title":"Neurobiol Aging"},{"key":"812_CR201","doi-asserted-by":"crossref","unstructured":"Zhou X, et al. Proteomic profiling reveals age-related changes in transporter proteins in the human blood-brain barrier. bioRxiv: the preprint server for biology. 2024.","DOI":"10.1101\/2024.07.26.604313"},{"key":"812_CR202","doi-asserted-by":"publisher","unstructured":"Cohen J, Torres C. Astrocyte senescence: evidence and significance. Aging Cell. 2019;18(3):e12937. https:\/\/doi.org\/10.1111\/acel.12937.","DOI":"10.1111\/acel.12937"},{"issue":"6","key":"812_CR203","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1111\/nan.12375","volume":"43","author":"J Duncombe","year":"2017","unstructured":"Duncombe J, Lennen RJ, Jansen MA, Marshall I, Wardlaw JM, Horsburgh K. Ageing causes prominent neurovascular dysfunction associated with loss of astrocytic contacts and gliosis. Neuropathol Appl Neurobio. 2017;43(6):477\u201391. https:\/\/doi.org\/10.1111\/nan.12375.","journal-title":"Neuropathol Appl Neurobio"},{"key":"812_CR204","doi-asserted-by":"publisher","unstructured":"Clarke LE, Liddelow SA, Chakraborty C, M\u00fcnch AE, Heiman M, Barres BA. Normal aging induces A1-like astrocyte reactivity. Proc Natl Acad Sci USA. 2018;115(8):E1896\u2013905. https:\/\/doi.org\/10.1073\/pnas.1800165115.","DOI":"10.1073\/pnas.1800165115"},{"key":"812_CR205","doi-asserted-by":"publisher","unstructured":"Zheng J, Lu J, Mei S, Wu H, Sun Z, Fang Y, et al. Ceria nanoparticles ameliorate white matter injury after intracerebral hemorrhage: microglia-astrocyte involvement in remyelination. J Neuroinflammation. 2021;18(1). https:\/\/doi.org\/10.1186\/s12974-021-02101-6.","DOI":"10.1186\/s12974-021-02101-6"},{"issue":"5","key":"812_CR206","doi-asserted-by":"publisher","first-page":"1155","DOI":"10.1002\/glia.23955","volume":"69","author":"Y Wei","year":"2021","unstructured":"Wei Y, Chen T, Bosco DB, Xie M, Zheng J, Dheer A, et al. The complement C3-C3aR pathway mediates microglia\u2013astrocyte interaction following status epilepticus. Glia. 2021;69(5):1155\u201369. https:\/\/doi.org\/10.1002\/glia.23955.","journal-title":"Glia"},{"key":"812_CR207","doi-asserted-by":"publisher","unstructured":"Preininger MK, Zaytseva D, Lin JM, Kaufer D. Blood\u2013brain barrier dysfunction promotes astrocyte senescence through albumin-induced TGF\u03b2 signaling activation. Aging Cell. 2023;22(2):e13747. https:\/\/doi.org\/10.1111\/acel.13747.","DOI":"10.1111\/acel.13747"},{"issue":"7638","key":"812_CR208","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1038\/nature21029","volume":"541","author":"SA Liddelow","year":"2017","unstructured":"Liddelow SA, Guttenplan KA, Clarke LE, Bennett FC, Bohlen CJ, Schirmer L, et al. Neurotoxic reactive astrocytes are induced by activated microglia. Nature. 2017;541(7638):481\u201387. https:\/\/doi.org\/10.1038\/nature21029.","journal-title":"Nature"},{"issue":"5","key":"812_CR209","doi-asserted-by":"publisher","first-page":"810","DOI":"10.1016\/j.cell.2011.02.018","volume":"144","author":"A Suzuki","year":"2011","unstructured":"Suzuki A, Stern S, Bozdagi O, Huntley G, Walker R, Magistretti P, et al. Astrocyte-neuron lactate transport is required for long-term memory formation. Cell. 2011;144(5):810\u201323. https:\/\/doi.org\/10.1016\/j.cell.2011.02.018.","journal-title":"Cell"},{"issue":"4","key":"812_CR210","doi-asserted-by":"publisher","first-page":"941","DOI":"10.3390\/ijms20040941","volume":"20","author":"M Morita","year":"2019","unstructured":"Morita M, Ikeshima-Kataoka H, Kreft M, Vardjan N, Zorec R, Noda M. Metabolic plasticity of astrocytes and aging of the brain. IJMS. 2019;20(4):941. https:\/\/doi.org\/10.3390\/ijms20040941.","journal-title":"IJMS"},{"issue":"1","key":"812_CR211","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1002\/glia.22731","volume":"63","author":"B G\u00f6rg","year":"2015","unstructured":"G\u00f6rg B, Karababa A, Shafigullina A, Bidmon HJ, H\u00e4ussinger D. Ammonia-induced senescence in cultured rat astrocytes and in human cerebral cortex in hepatic encephalopathy. Glia. 2015;63(1):37\u201350. https:\/\/doi.org\/10.1002\/glia.22731.","journal-title":"Glia"},{"key":"812_CR212","doi-asserted-by":"publisher","first-page":"101647","DOI":"10.1016\/j.molmet.2022.101647","volume":"66","author":"SJ Geffken","year":"2022","unstructured":"Geffken SJ, Moon S, Smith CO, Tang S, Lee HH, Lewis K, et al. Insulin and IGF-1 elicit robust transcriptional regulation to modulate autophagy in astrocytes. Mol Metab. 2022;66:101647. https:\/\/doi.org\/10.1016\/j.molmet.2022.101647.","journal-title":"Mol Metab"},{"issue":"3","key":"812_CR213","doi-asserted-by":"publisher","first-page":"523","DOI":"10.14283\/jpad.2022.42","volume":"9","author":"Q Behfar","year":"2022","unstructured":"Behfar Q, Ramirez Zuniga A, Martino-Adami PVA. Aging, senescence, and Dementia. J Sport Hist Prev Alzheimers Disease. 2022;9(3):523\u201331. https:\/\/doi.org\/10.14283\/jpad.2022.42.","journal-title":"J Sport Hist Prev Alzheimers Disease"},{"key":"812_CR214","doi-asserted-by":"publisher","first-page":"771453","DOI":"10.3389\/fimmu.2021.771453","volume":"12","author":"EA Zuiderwijk-Sick","year":"2021","unstructured":"Zuiderwijk-Sick EA, van der Putten C, Timmerman R, Veth J, Pasini EM, van Straalen L, et al. Exposure of microglia to Interleukin-4 represses NF-\u03baB-Dependent transcription of Toll-like receptor-induced cytokines. Front. Immunol. 2021;12:771453. https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2021.771453\/full.","journal-title":"Front. Immunol"},{"issue":"11","key":"812_CR215","first-page":"1669","volume":"15","author":"A Ungvari","year":"2025","unstructured":"Ungvari A, K\u00e1llai A, Stankovics L, Lendvai-Emmert D, Gulej R, Pal E, et al. Age-related alterations of cerebral autoregulation. Life (Basel, Switz). 2025;15(11):1669. https:\/\/pubmed.ncbi.nlm.nih.gov\/41302094\/.","journal-title":"Life (Basel, Switz)"},{"issue":"4","key":"812_CR216","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1017\/S0317167100000421","volume":"26","author":"ZG Huang","year":"1999","unstructured":"Huang ZG, Xue D, Karbalai H, Buchan AM, Huang ZG, Xue D, et al. Biphasic opening of the blood-brain barrier following transient focal ischemia: effects of hypothermia. Can J Neurol Sci. 1999;26(4):298\u2013304. https:\/\/doi.org\/10.1017\/S0317167100000421.","journal-title":"Can J Neurol Sci"},{"key":"812_CR217","doi-asserted-by":"crossref","unstructured":"Lassmann H. Heterogeneity of multiple sclerosis: implications for therapy targeting regeneration. Ernst Schering ResearchFound Workshop. 2005;11\u201322.","DOI":"10.1007\/3-540-27626-2_2"},{"issue":"2","key":"812_CR218","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1002\/path.1434","volume":"201","author":"J Kirk","year":"2003","unstructured":"Kirk J, Plumb J, Mirakhur M, McQuaid S. Tight junctional abnormality in multiple sclerosis white matter affects all calibres of vessel and is associated with blood\u2013brain barrier leakage and active demyelination. The J Pathol. 2003;201(2):319\u201327. https:\/\/doi.org\/10.1002\/path.1434.","journal-title":"The J Pathol"},{"key":"812_CR219","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1016\/j.brainres.2007.04.044","volume":"1157","author":"S Garbuzova-Davis","year":"2007","unstructured":"Garbuzova-Davis S, Haller E, Saporta S, Kolomey I, Nicosia SV, Sanberg PR. Ultrastructure of blood\u2013brain barrier and blood\u2013spinal cord barrier in SOD1 mice modeling ALS. Brain Res. 2007;1157:126\u201337. https:\/\/doi.org\/10.1016\/j.brainres.2007.04.044.","journal-title":"Brain Res"},{"key":"812_CR220","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1016\/j.brainres.2009.09.018","volume":"1301","author":"C Nicaise","year":"2009","unstructured":"Nicaise C, Mitrecic D, Demetter P, De Decker R, Authelet M, Boom A, et al. Impaired blood\u2013brain and blood\u2013spinal cord barriers in mutant SOD1-linked ALS rat. Brain Res. 2009;1301:152\u201362. https:\/\/doi.org\/10.1016\/j.brainres.2009.09.018.","journal-title":"Brain Res"},{"key":"812_CR221","doi-asserted-by":"publisher","unstructured":"Dro\u017adzik M, Bia\u0142ecka M, My\u015bliwiec K, Honczarenko K, Stankiewicz J, Sych Z. Polymorphism in the P-glycoprotein drug transporter MDR1 gene: a possible link between environmental and genetic factors in Parkinson\u2019s disease. Pharmacogenetics. 2003;13(5):259\u201363. https:\/\/doi.org\/10.1097\/00008571-200305000-00004.","DOI":"10.1097\/00008571-200305000-00004"},{"issue":"1","key":"812_CR222","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1007\/s00702-011-0684-8","volume":"119","author":"B Desai Bradaric","year":"2012","unstructured":"Desai Bradaric B, Patel A, Schneider JA, Carvey PM, Hendey B. Evidence for angiogenesis in Parkinson\u2019s disease, incidental lewy body disease, and progressive supranuclear palsy. J Neural Transm. 2012;119(1):59\u201371. https:\/\/doi.org\/10.1007\/s00702-011-0684-8.","journal-title":"J Neural Transm"},{"issue":"7","key":"812_CR223","doi-asserted-by":"publisher","first-page":"578","DOI":"10.2174\/156720510793499066","volume":"7","author":"T Pflanzner","year":"2010","unstructured":"Pflanzner T, Kuhlmann CR, Pietrzik CU. Blood-brain-barrier models for the investigation of transporter- and receptor-mediated amyloid-\u03b2 clearance in Alzheimers disease. CAR. 2010;7(7):578\u201390. https:\/\/doi.org\/10.2174\/156720510793499066.","journal-title":"CAR"},{"key":"812_CR224","doi-asserted-by":"publisher","first-page":"5541","DOI":"10.2147\/IJN.S200490","volume":"14","author":"S Tiwari","year":"2019","unstructured":"Tiwari S, Atluri V, Kaushik A, Yndart A, Nair M. Alzheimer\u2019s disease: pathogenesis, diagnostics, and therapeutics. IJN, 14, 5541\u201354 (2019). https:\/\/doi.org\/10.2147\/IJN.S200490.","journal-title":"IJN"},{"issue":"6","key":"812_CR225","doi-asserted-by":"publisher","first-page":"595","DOI":"10.15252\/emmm.201606210","volume":"8","author":"DJ Selkoe","year":"2016","unstructured":"Selkoe DJ, Hardy J. The amyloid hypothesis of Alzheimer\u2019s disease at 25 years. EMBO Mol Med. 2016;8(6):595\u2013608. https:\/\/doi.org\/10.15252\/emmm.201606210.","journal-title":"EMBO Mol Med"},{"issue":"1","key":"812_CR226","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1186\/s40035-020-00195-1","volume":"9","author":"Y Cheng","year":"2020","unstructured":"Cheng Y, Tian D-Y, Wang Y-J. Peripheral clearance of brain-derived A\u03b2 in Alzheimer\u2019s disease: pathophysiology and therapeutic perspectives. Transl Neurodegener. 2020;9(1):16. https:\/\/doi.org\/10.1186\/s40035-020-00195-1.","journal-title":"Transl Neurodegener"},{"issue":"10","key":"812_CR227","doi-asserted-by":"publisher","first-page":"7234","DOI":"10.1007\/s12035-019-1594-2","volume":"56","author":"B van Gool","year":"2019","unstructured":"van Gool B, Storck SE, Reekmans SM, Lechat B, Gordts PLSM, Pradier L, et al. LRP1 has a predominant role in production over clearance of A\u03b2 in a mouse model of Alzheimer\u2019s disease. Mol Neurobiol. 2019;56(10):7234\u201345. https:\/\/doi.org\/10.1007\/s12035-019-1594-2.","journal-title":"Mol Neurobiol"},{"issue":"4","key":"812_CR228","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1007\/s00401-006-0115-3","volume":"112","author":"JE Donahue","year":"2006","unstructured":"Donahue JE, Flaherty SL, Johanson CE, Duncan JA, Silverberg GD, Miller MC, et al. RAGE, LRP-1, and amyloid-beta protein in Alzheimer\u2019s disease. Acta Neuropathologica. 2006;112(4):405\u201315. https:\/\/doi.org\/10.1007\/s00401-006-0115-3.","journal-title":"Acta Neuropathologica"},{"key":"812_CR229","doi-asserted-by":"publisher","first-page":"1669405","DOI":"10.3389\/fnagi.2025.1669405","volume":"17","author":"Y Deng","year":"2026","unstructured":"Deng Y, Yin H, Lu Z, Lan H, Liu W, Zuo C, et al. LRP1 at the crossroads of A\u03b2 clearance and therapeutic targeting in Alzheimer\u2019s disease. Front Aging Neurosci. 2026;17:1669405. https:\/\/doi.org\/10.3389\/fnagi.2025.1669405.","journal-title":"Front Aging Neurosci"},{"issue":"5","key":"812_CR230","doi-asserted-by":"publisher","first-page":"432","DOI":"10.2174\/156720508785908937","volume":"5","author":"B Jeynes","year":"2008","unstructured":"Jeynes B, Provias J. Evidence for altered LRP\/RAGE expression in Alzheimer lesion pathogenesis. CAR. 2008;5(5):432\u201337. https:\/\/doi.org\/10.2174\/156720508785908937.","journal-title":"CAR"},{"issue":"7693","key":"812_CR231","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1038\/nature25739","volume":"554","author":"M Vanlandewijck","year":"2018","unstructured":"Vanlandewijck M, He L, M\u00e4e MA, Andrae J, Ando K, Del Gaudio F, et al. A molecular atlas of cell types and zonation in the brain vasculature. Nature. 2018;554(7693):475\u201380. https:\/\/doi.org\/10.1038\/nature25739.","journal-title":"Nature"},{"issue":"2","key":"812_CR232","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1186\/alzrt110","volume":"4","author":"G Xu","year":"2012","unstructured":"Xu G, Green CC, Fromholt SE, Borchelt DR. Reduction of low-density lipoprotein receptor-related protein (LRP1) in hippocampal neurons does not proportionately reduce, or otherwise alter, amyloid deposition in APPswe\/PS1dE9 transgenic mice. Alz Res Ther. 2012;4(2):12. https:\/\/link.springer.com\/article\/10.1186\/alzrt110?utm_source=chatgpt.com#Sec15.","journal-title":"Alz Res Ther"},{"issue":"9","key":"812_CR233","doi-asserted-by":"publisher","first-page":"6383","DOI":"10.1007\/s12035-024-03990-3","volume":"61","author":"S Petralla","year":"2024","unstructured":"Petralla S, Saveleva L, Kanninen KM, Oster JS, Panayotova M, Fricker G, et al. Increased expression of transferrin receptor 1 in the brain cortex of 5xFAD mouse model of Alzheimer\u2019s disease is associated with activation of HIF-1 signaling pathway. Mol Neurobiol. 2024;61(9):6383\u201394. https:\/\/doi.org\/10.1007\/s12035-024-03990-3.","journal-title":"Mol Neurobiol"},{"issue":"2","key":"812_CR234","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1021\/acs.molpharmaceut.8b00870","volume":"16","author":"P Bourassa","year":"2019","unstructured":"Bourassa P, Alata W, Tremblay C, Paris-Robidas S, Calon F. Transferrin receptor-mediated uptake at the blood\u2013brain barrier is not impaired by Alzheimer\u2019s disease Neuropathology. Mol. Pharm. 2019;16(2):583\u201394. https:\/\/doi.org\/10.1021\/acs.molpharmaceut.8b00870.","journal-title":"Mol. Pharm"},{"issue":"1","key":"812_CR235","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1186\/s12987-025-00732-y","volume":"22","author":"F Calon","year":"2025","unstructured":"Calon F. The duality of the BBB: breaking the myth of the blood-brain barrier breakdown. Fluids Barriers CNS. 2025;22(1):120. https:\/\/doi.org\/10.1186\/s12987-025-00732-y.","journal-title":"Fluids Barriers CNS"},{"issue":"8","key":"812_CR236","doi-asserted-by":"publisher","first-page":"516","DOI":"10.1016\/S0025-6196(26)01499-0","volume":"56","author":"BM Onofrio","year":"1981","unstructured":"Onofrio BM, Yaksh TL, Arnold PG. Continuous low-dose intrathecal morphine administration in the treatment of chronic pain of malignant origin. Mayo Clinic Proc. 1981;56(8):516\u201320. https:\/\/doi.org\/10.1016\/S0025-6196(26)01499-0.","journal-title":"Mayo Clinic Proc"},{"issue":"5","key":"812_CR237","first-page":"237","volume":"31","author":"JC Cradock","year":"1977","unstructured":"Cradock JC, Kleinman LM, Davignon JP. Intrathecal injections--a review of pharmaceutical factors. Bull Parenter Drug Assoc. 1977;31(5):237\u201347.","journal-title":"Bull Parenter Drug Assoc"},{"issue":"3","key":"812_CR238","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1016\/0163-7258(82)90073-0","volume":"19","author":"N Bodor","year":"1982","unstructured":"Bodor N, Brewster ME. Problems of delivery of drugs to the brain. Pharmacol Ther. 1982;19(3):337\u201386. https:\/\/doi.org\/10.1016\/0163-7258(82)90073-0.","journal-title":"Pharmacol Ther"},{"issue":"2","key":"812_CR239","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1002\/jps.2600640203","volume":"64","author":"AA Sinkula","year":"1975","unstructured":"Sinkula AA, Yalkowsky SH. Rationale for design of biologically reversible drug derivatives: prodrugs. J Pharm Sci. 1975;64(2):181\u2013210. https:\/\/doi.org\/10.1002\/jps.2600640203.","journal-title":"J Pharm Sci"},{"key":"812_CR240","doi-asserted-by":"crossref","unstructured":"Ozawa T, Rodriguez M, Zhao G, Yao TW, Fischer W-N, Jandeleit B, et al. A novel blood-brain barrier-permeable Chemotherapeutic Agent for the treatment of glioblastoma. Cureus. 2021;13:e17595. https:\/\/pubmed.ncbi.nlm.nih.gov\/34646647\/.","DOI":"10.7759\/cureus.17595"},{"issue":"11","key":"812_CR241","doi-asserted-by":"publisher","first-page":"2110","DOI":"10.1158\/1535-7163.MCT-21-0140","volume":"20","author":"J Deng","year":"2021","unstructured":"Deng J, Chernikova SB, Wang Y, Rodriguez ML, Andersen SJ, Umeh-Garcia MC, et al. A novel brain-permeant Chemotherapeutic Agent for the treatment of brain metastasis in triple-negative breast cancer. Mol Cancer Ther. 2021;20(11):2110\u201316. https:\/\/doi.org\/10.1158\/1535-7163.MCT-21-0140.","journal-title":"Mol Cancer Ther"},{"issue":"21","key":"812_CR242","doi-asserted-by":"publisher","first-page":"2018","DOI":"10.1056\/NEJMoa2027187","volume":"383","author":"AT Shaw","year":"2020","unstructured":"Shaw AT, Bauer TM, de Marinis F, Felip E, Goto Y, Liu G, et al. First-line lorlatinib or crizotinib in Advanced ALK-Positive lung cancer. N Engl J Med. 2020;383(21):2018\u201329. https:\/\/doi.org\/10.1056\/NEJMoa2027187.","journal-title":"N Engl J Med"},{"key":"812_CR243","doi-asserted-by":"publisher","unstructured":"Yulyaningsih E, Suh JH, Fanok M, Chau R, Solanoy H, Takahashi R, et al. DNL343 is an investigational CNS penetrant eukaryotic initiation factor 2B activator that prevents and reverses the effects of neurodegeneration caused by the integrated stress response. eLife. 2024;12. https:\/\/doi.org\/10.7554\/eLife.92173.","DOI":"10.7554\/eLife.92173"},{"issue":"5","key":"812_CR244","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1038\/s41573-021-00139-y","volume":"20","author":"GC Terstappen","year":"2021","unstructured":"Terstappen GC, Meyer AH, Bell RD, Zhang W. Strategies for delivering therapeutics across the blood\u2013brain barrier. Nat Rev Drug Discov. 2021;20(5):362\u201383. https:\/\/doi.org\/10.1038\/s41573-021-00139-y.","journal-title":"Nat Rev Drug Discov"},{"issue":"5","key":"812_CR245","doi-asserted-by":"publisher","first-page":"1306","DOI":"10.1007\/s00259-023-06109-3","volume":"50","author":"N Stergiou","year":"2023","unstructured":"Stergiou N, Wuensche TE, Schreurs M, Mes I, Verlaan M, Kooijman EJM, et al. Application of 89Zr-DFO*-immuno-PET to assess improved target engagement of a bispecific anti-amyloid-\u00df monoclonal antibody. Eur J Nucl Med Mol Imag. 2023;50(5):1306\u201317. https:\/\/doi.org\/10.1007\/s00259-023-06109-3.","journal-title":"Eur J Nucl Med Mol Imag"},{"issue":"2","key":"812_CR246","doi-asserted-by":"publisher","first-page":"308","DOI":"10.7150\/thno.17155","volume":"7","author":"G Hultqvist","year":"2017","unstructured":"Hultqvist G, Syv\u00e4nen S, Fang XT, Lannfelt L, Sehlin D. Bivalent brain shuttle increases antibody uptake by monovalent binding to the transferrin receptor. Theranostics. 2017;7(2):308\u201318. https:\/\/doi.org\/10.7150\/thno.17155.","journal-title":"Theranostics"},{"issue":"16","key":"812_CR247","doi-asserted-by":"publisher","first-page":"7067","DOI":"10.7150\/thno.73509","volume":"12","author":"TE Wuensche","year":"2022","unstructured":"Wuensche TE, Stergiou N, Mes I, Verlaan M, Schreurs M, Kooijman EJM, et al. Advancing 89Zr-immuno-PET in neuroscience with a bispecific anti-amyloid-beta monoclonal antibody - the choice of chelator is essential. Theranostics. 2022;12(16):7067\u201379. https:\/\/doi.org\/10.7150\/thno.73509.","journal-title":"Theranostics"},{"key":"812_CR248","doi-asserted-by":"publisher","unstructured":"Yu YJ, Atwal JK, Zhang Y, Tong RK, Wildsmith KR, Tan C, et al. Therapeutic bispecific antibodies cross the blood-brain barrier in nonhuman primates. Sci Transl Med. 2014;6(261):261ra154. https:\/\/doi.org\/10.1126\/scitranslmed.3009835.","DOI":"10.1126\/scitranslmed.3009835"},{"issue":"3","key":"812_CR249","doi-asserted-by":"publisher","first-page":"865","DOI":"10.1093\/brain\/awac459","volume":"146","author":"Y Meng","year":"2023","unstructured":"Meng Y, Goubran M, Rabin JS, McSweeney M, Ottoy J, Pople CB, et al. Blood\u2013brain barrier opening of the default mode network in Alzheimer\u2019s disease with magnetic resonance-guided focused ultrasound. Brain: J Neurol. 2023;146(3):865\u201372. https:\/\/doi.org\/10.1093\/brain\/awac459.","journal-title":"Brain: J Neurol"},{"issue":"1","key":"812_CR250","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1056\/NEJMoa2308719","volume":"390","author":"AR Rezai","year":"2024","unstructured":"Rezai AR, D\u2019Haese P-F, Finomore V, Carpenter J, Ranjan M, Wilhelmsen K, et al. Ultrasound blood\u2013brain barrier opening and aducanumab in Alzheimer\u2019s disease. N Engl J Med. 2024;390(1):55\u201362. https:\/\/doi.org\/10.1056\/NEJMoa2308719.","journal-title":"N Engl J Med"},{"issue":"10","key":"812_CR251","doi-asserted-by":"publisher","first-page":"1789","DOI":"10.1093\/neuonc\/noab057","volume":"23","author":"Y Meng","year":"2021","unstructured":"Meng Y, Pople CB, Suppiah S, Llinas M, Huang Y, Sahgal A, et al. MR-guided focused ultrasound liquid biopsy enriches circulating biomarkers in patients with brain tumors. Neuro-Oncology. 2021;23(10):1789\u201397. https:\/\/doi.org\/10.1093\/neuonc\/noab057.","journal-title":"Neuro-Oncology"},{"issue":"5","key":"812_CR252","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1016\/S1470-2045(23)00112-2","volume":"24","author":"AM Sonabend","year":"2023","unstructured":"Sonabend AM, Gould A, Amidei C, Ward R, Schmidt KA, Zhang DY, et al. Repeated blood\u2013brain barrier opening with an implantable ultrasound device for delivery of albumin-bound paclitaxel in patients with recurrent glioblastoma: a phase 1 trial. The Lancet Oncol. 2023;24(5):509\u201322. https:\/\/doi.org\/10.1016\/S1470-2045(23)00112-2.","journal-title":"The Lancet Oncol"},{"key":"812_CR253","doi-asserted-by":"publisher","unstructured":"Epelbaum S, Burgos N, Canney M, Matthews D, Houot M, Santin MD, et al. Pilot study of repeated blood-brain barrier disruption in patients with mild Alzheimer\u2019s disease with an implantable ultrasound device. Alz Res Ther. 2022;14(1). https:\/\/doi.org\/10.1186\/s13195-022-00981-1.","DOI":"10.1186\/s13195-022-00981-1"},{"key":"812_CR254","doi-asserted-by":"publisher","unstructured":"Cummings JL. Maximizing the benefit and managing the risk of anti-amyloid monoclonal antibody therapy for Alzheimer\u2019s disease: strategies and research directions. Neurotherapeutics: J The Am Soc Exp NeuroTherapeutics. 2025;22(3):e00570. https:\/\/doi.org\/10.1016\/j.neurot.2025.e00570.","DOI":"10.1016\/j.neurot.2025.e00570"},{"issue":"6740","key":"812_CR255","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1038\/22124","volume":"400","author":"D Schenk","year":"1999","unstructured":"Schenk D, Barbour R, Dunn W, Gordon G, Grajeda H, Guido T, et al. Immunization with amyloid-\u03b2 attenuates Alzheimer-disease-like pathology in the PDAPP mouse. Nature. 1999;400(6740):173\u201377. https:\/\/doi.org\/10.1038\/22124.","journal-title":"Nature"},{"issue":"1","key":"812_CR256","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1212\/01.WNL.0000073623.84147.A8","volume":"61","author":"J-M Orgogozo","year":"2003","unstructured":"Orgogozo J-M, Gilman S, Dartigues J-F, Laurent B, Puel M, Kirby LC, et al. Subacute meningoencephalitis in a subset of patients with AD after A\u03b242 immunization. Neurology. 2003;61(1):46\u201354. https:\/\/doi.org\/10.1212\/01.WNL.0000073623.84147.A8.","journal-title":"Neurology"},{"issue":"4","key":"812_CR257","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1056\/NEJMoa1312889","volume":"370","author":"RS Doody","year":"2014","unstructured":"Doody RS, Thomas RG, Farlow M, Iwatsubo T, Vellas B, Joffe S, et al. Phase 3 trials of solanezumab for mild-to-moderate Alzheimer\u2019s disease. N Engl J Med. 2014;370(4):311\u201321. https:\/\/doi.org\/10.1056\/NEJMoa1312889.","journal-title":"N Engl J Med"},{"issue":"7618","key":"812_CR258","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1038\/nature19323","volume":"537","author":"J Sevigny","year":"2016","unstructured":"Sevigny J, Chiao P, Bussi\u00e8re T, Weinreb PH, Williams L, Maier M, et al. The antibody aducanumab reduces A\u03b2 plaques in Alzheimer\u2019s disease. Nature. 2016;537(7618):50\u201356. https:\/\/doi.org\/10.1038\/nature19323.","journal-title":"Nature"},{"issue":"6","key":"812_CR259","doi-asserted-by":"publisher","first-page":"512","DOI":"10.1001\/jama.2023.13239","volume":"330","author":"JR Sims","year":"2023","unstructured":"Sims JR, Zimmer JA, Evans CD, Lu M, Ardayfio P, Sparks J, et al. Donanemab in early symptomatic Alzheimer disease: the TRAILBLAZER-ALZ 2 randomized clinical trial. JAMA. 2023;330(6):512\u201327. https:\/\/doi.org\/10.1001\/jama.2023.13239.","journal-title":"JAMA"},{"issue":"1","key":"812_CR260","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1056\/NEJMoa2212948","volume":"388","author":"CH van Dyck","year":"2023","unstructured":"van Dyck CH, Swanson CJ, Aisen P, Bateman RJ, Chen C, Gee M, et al. Lecanemab in early Alzheimer\u2019s disease. N Engl J Med. 2023;388(1):9\u201321. https:\/\/doi.org\/10.1056\/NEJMoa2212948.","journal-title":"N Engl J Med"},{"issue":"3","key":"812_CR261","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1159\/000316530","volume":"8","author":"D Sehlin","year":"2011","unstructured":"Sehlin D, Hedlund M, Lord A, Englund H, Gellerfors P, Paulie S, et al. Heavy-chain complementarity-determining regions determine conformation selectivity of anti-a\u03b2 antibodies. Neurodegener Dis. 2011;8(3):117\u201323. https:\/\/doi.org\/10.1159\/000316530.","journal-title":"Neurodegener Dis"},{"key":"812_CR262","doi-asserted-by":"publisher","unstructured":"Sehlin D, Englund H, Simu B, Karlsson M, Ingelsson M, Nikolajeff F, et al. Large aggregates are the major soluble A\u03b2 species in AD brain fractionated with density gradient ultracentrifugation. PLoS One. 2012;7(2):e32014. https:\/\/doi.org\/10.1371\/journal.pone.0032014.","DOI":"10.1371\/journal.pone.0032014"},{"issue":"2","key":"812_CR263","doi-asserted-by":"publisher","first-page":"575","DOI":"10.3233\/JAD-140741","volume":"43","author":"S Tucker","year":"2015","unstructured":"Tucker S, M\u00f6ller C, Tegerstedt K, Lord A, Laudon H, Sj\u00f6dahl J, et al. The murine version of BAN2401 (mAb158) selectively reduces amyloid-\u03b2 protofibrils in brain and cerebrospinal fluid of tg-ArcSwe mice. J Alzheimer\u2019s Disease: JAD. 2015;43(2):575\u201388. https:\/\/doi.org\/10.3233\/JAD-140741.","journal-title":"J Alzheimer\u2019s Disease: JAD"},{"issue":"1","key":"812_CR264","doi-asserted-by":"publisher","first-page":"29","DOI":"10.3233\/JAD-130029","volume":"37","author":"K Magnusson","year":"2013","unstructured":"Magnusson K, Sehlin D, Syv\u00e4nen S, Svedberg MM, Philipson O, S\u00f6derberg L, et al. Specific uptake of an amyloid-\u03b2 protofibril-binding antibody-tracer in A\u03b2PP transgenic mouse brain. J Alzheimer\u2019s Disease: JAD. 2013;37(1):29\u201340. https:\/\/doi.org\/10.3233\/JAD-130029.","journal-title":"J Alzheimer\u2019s Disease: JAD"},{"key":"812_CR265","doi-asserted-by":"publisher","unstructured":"Swanson CJ, Zhang Y, Dhadda S, Wang J, Kaplow J, Lai RYK, et al. A randomized, double-blind, phase 2b proof-of-concept clinical trial in early Alzheimer\u2019s disease with lecanemab, an anti-A\u03b2 protofibril antibody. Alz Res Ther. 2021;13(1). https:\/\/doi.org\/10.1186\/s13195-021-00813-8.","DOI":"10.1186\/s13195-021-00813-8"},{"issue":"3","key":"812_CR266","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1016\/j.nbd.2009.08.007","volume":"36","author":"A Lord","year":"2009","unstructured":"Lord A, Gumucio A, Englund H, Sehlin D, Sundquist VS, S\u00f6derberg L, et al. An amyloid-\u03b2 protofibril-selective antibody prevents amyloid formation in a mouse model of Alzheimer\u2019s disease. Neurobiol Disease. 2009;36(3):425\u201334. https:\/\/doi.org\/10.1016\/j.nbd.2009.08.007.","journal-title":"Neurobiol Disease"},{"issue":"4","key":"812_CR267","doi-asserted-by":"publisher","first-page":"100094","DOI":"10.1016\/j.tjpad.2025.100094","volume":"12","author":"N Villain","year":"2025","unstructured":"Villain N, Planche V, Lilamand M, Cordonnier C, Soto-Martin M, Mollion H, et al. Lecanemab for early Alzheimer\u2019s disease: appropriate use recommendations from the French federation of memory clinics. J Sport Hist Prev Alzheimers Disease. 2025;12(4):100094. https:\/\/doi.org\/10.1016\/j.tjpad.2025.100094.","journal-title":"J Sport Hist Prev Alzheimers Disease"},{"issue":"1","key":"812_CR268","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/S1474-4422(23)00449-0","volume":"23","author":"J Delrieu","year":"2024","unstructured":"Delrieu J, Andrieu S, Vellas B. Dementia research in 2023: the year of anti-amyloid immunotherapy. The Lancet Neurol. 2024;23(1):13\u201315. https:\/\/doi.org\/10.1016\/S1474-4422(23)00449-0.","journal-title":"The Lancet Neurol"},{"issue":"4","key":"812_CR269","doi-asserted-by":"publisher","first-page":"771","DOI":"10.14283\/jpad.2023.123","volume":"10","author":"S Cohen","year":"2023","unstructured":"Cohen S, van Dyck CH, Gee M, Doherty T, Kanekiyo M, Dhadda S, et al. Lecanemab Clarity AD: quality-of-Life results from a randomized, Double-blind phase 3 trial in early Alzheimer\u2019s disease. J Sport Hist Prev Alzheimers Disease. 2023;10(4):771\u201377. https:\/\/doi.org\/10.14283\/jpad.2023.123.","journal-title":"J Sport Hist Prev Alzheimers Disease"},{"issue":"1","key":"812_CR270","doi-asserted-by":"publisher","first-page":"8220","DOI":"10.1038\/s41467-023-43933-5","volume":"14","author":"E Solopova","year":"2023","unstructured":"Solopova E, Romero-Fernandez W, Harmsen H, Ventura-Antunes L, Wang E, Shostak A, et al. Fatal iatrogenic cerebral \u03b2-amyloid-related arteritis in a woman treated with lecanemab for Alzheimer\u2019s disease. Nat Commun. 2023;14(1):8220. https:\/\/doi.org\/10.1038\/s41467-023-43933-5.","journal-title":"Nat Commun"},{"issue":"1","key":"812_CR271","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1186\/s13195-024-01441-8","volume":"16","author":"LS Honig","year":"2024","unstructured":"Honig LS, Sabbagh MN, van Dyck CH, Sperling RA, Hersch S, Matta A, et al. Updated safety results from phase 3 lecanemab study in early Alzheimer\u2019s disease. Alz Res Ther. 2024;16(1):105. https:\/\/doi.org\/10.1186\/s13195-024-01441-8.","journal-title":"Alz Res Ther"},{"issue":"5","key":"812_CR272","doi-asserted-by":"publisher","first-page":"478","DOI":"10.1056\/NEJMc2215148","volume":"388","author":"NJ Reish","year":"2023","unstructured":"Reish NJ, Jamshidi P, Stamm B, Flanagan ME, Sugg E, Tang M, et al. Multiple cerebral hemorrhages in a patient receiving lecanemab and treated with t-PA for stroke. N Engl J Med. 2023;388(5):478\u201379. https:\/\/doi.org\/10.1056\/NEJMc2215148.","journal-title":"N Engl J Med"},{"key":"812_CR273","doi-asserted-by":"publisher","first-page":"102620","DOI":"10.1016\/j.arr.2024.102620","volume":"104","author":"N Arroyo-Pacheco","year":"2025","unstructured":"Arroyo-Pacheco N, Sarmiento-Blanco S, Vergara-Cadavid G, Castro-Leones M, Contreras-Puentes N. Monoclonal therapy with lecanemab in the treatment of mild Alzheimer\u2019s disease: a systematic review and meta-analysis. Ageing Res Rev. 2025;104:102620. https:\/\/doi.org\/10.1016\/j.arr.2024.102620.","journal-title":"Ageing Res Rev"},{"issue":"18","key":"812_CR274","doi-asserted-by":"publisher","first-page":"1691","DOI":"10.1056\/NEJMoa2100708","volume":"384","author":"MA Mintun","year":"2021","unstructured":"Mintun MA, Lo AC, Duggan Evans C, Wessels AM, Ardayfio PA, Andersen SW, et al. Donanemab in early Alzheimer\u2019s disease. N Engl J Med. 2021;384(18):1691\u2013704. https:\/\/doi.org\/10.1056\/NEJMoa2100708.","journal-title":"N Engl J Med"},{"key":"812_CR275","doi-asserted-by":"publisher","unstructured":"Ardayfio P, Mullins GR, Khanna R, Zimmer JA, Wang H, Nery ESM, et al. Infusion-related reactions in donanemab-treated participants with early symptomatic Alzheimer\u2019s disease. A D Transl Res Clin Interv. 2026;12(1):e70229. https:\/\/doi.org\/10.1002\/trc2.70229.","DOI":"10.1002\/trc2.70229"},{"issue":"10","key":"812_CR276","doi-asserted-by":"publisher","first-page":"1313","DOI":"10.1007\/s40265-024-02087-4","volume":"84","author":"C Kang","year":"2024","unstructured":"Kang C. Donanemab: first approval. Drugs. 2024;84(10):1313\u201318. https:\/\/doi.org\/10.1007\/s40265-024-02087-4.","journal-title":"Drugs"},{"issue":"1","key":"812_CR277","doi-asserted-by":"publisher","first-page":"49","DOI":"10.3233\/JAD-2011-110977","volume":"28","author":"B Bohrmann","year":"2012","unstructured":"Bohrmann B, Baumann K, Benz J, Gerber F, Huber W, Knoflach F, et al. Gantenerumab: a novel human anti-A\u03b2 antibody demonstrates sustained cerebral amyloid-\u03b2 binding and elicits cell-mediated removal of human amyloid-\u03b2. J Alzheimer\u2019s Disease: JAD. 2012;28(1):49\u201369. https:\/\/doi.org\/10.3233\/JAD-2011-110977.","journal-title":"J Alzheimer\u2019s Disease: JAD"},{"issue":"2","key":"812_CR278","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1001\/archneurol.2011.1538","volume":"69","author":"S Ostrowitzki","year":"2012","unstructured":"Ostrowitzki S, et al. Mechanism of amyloid removal in patients with Alzheimer disease treated with gantenerumab. Arch Neurol. 2012;69(2):198\u2013207. https:\/\/doi.org\/10.1001\/archneurol.2011.1538.","journal-title":"Arch Neurol"},{"issue":"1","key":"812_CR279","doi-asserted-by":"publisher","first-page":"10396","DOI":"10.1038\/s41598-017-11220-1","volume":"7","author":"KB Johnsen","year":"2017","unstructured":"Johnsen KB, Burkhart A, Melander F, Kempen PJ, Vejlebo JB, Siupka P, et al. Targeting transferrin receptors at the blood-brain barrier improves the uptake of immunoliposomes and subsequent cargo transport into the brain parenchyma. Sci Rep. 2017;7(1):10396. https:\/\/doi.org\/10.1038\/s41598-017-11220-1.","journal-title":"Sci Rep"},{"key":"812_CR280","doi-asserted-by":"publisher","unstructured":"Pizzo ME, Plowey ED, Khoury N, Kwan W, Abettan J, DeVos SL, et al. Transferrin receptor\u2013targeted anti-amyloid antibody enhances brain delivery and mitigates ARIA. Sci (New Y, N.Y.). 2025;389(6760):eads3204. https:\/\/doi.org\/10.1126\/science.ads3204.","DOI":"10.1126\/science.ads3204"},{"key":"812_CR281","doi-asserted-by":"publisher","unstructured":"Stocki P, Szary J, Rasmussen CLM, Demydchuk M, Northall L, Logan DB, et al. Blood-brain barrier transport using a high affinity, brain-selective VNAR antibody targeting transferrin receptor 1. The FASEB J. 2021;35(2):e21172. https:\/\/doi.org\/10.1096\/fj.202001787R.","DOI":"10.1096\/fj.202001787R"},{"issue":"3","key":"812_CR282","doi-asserted-by":"publisher","first-page":"739","DOI":"10.3390\/pharmaceutics15030739","volume":"15","author":"P Stocki","year":"2023","unstructured":"Stocki P, Szary J, Demydchuk M, Northall L, Rasmussen CLM, Logan DB, et al. CDR3 variants of the TXB2 shuttle with increased TfR1 Association rate and enhanced brain penetration. Pharmaceutics. 2023;15(3):739. https:\/\/doi.org\/10.3390\/pharmaceutics15030739.","journal-title":"Pharmaceutics"},{"issue":"2","key":"812_CR283","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1016\/j.chembiol.2023.09.008","volume":"31","author":"G Pornnoppadol","year":"2024","unstructured":"Pornnoppadol G, Bond LG, Lucas MJ, Zupancic JM, Kuo Y-H, Zhang B, et al. Bispecific antibody shuttles targeting CD98hc mediate efficient and long-lived brain delivery of IgGs. Cell Chem Biol. 2024;31(2):361\u201372.e8. https:\/\/doi.org\/10.1016\/j.chembiol.2023.09.008.","journal-title":"Cell Chem Biol"},{"issue":"7","key":"812_CR284","doi-asserted-by":"publisher","first-page":"1264","DOI":"10.1021\/acschemneuro.4c00552","volume":"16","author":"JL Veire","year":"2025","unstructured":"Veire JL, Lucas MJ, Bond LG, Tripu DR, Tessier PM, Greineder CF. Comparative radiotracing quantifies brain cellular uptake and catabolism of bispecific antibodies targeting transferrin receptor and CD98hc. ACS Chem. Neurosci. 2025;16(7):1264\u201374. https:\/\/doi.org\/10.1021\/acschemneuro.4c00552.","journal-title":"ACS Chem. Neurosci"},{"issue":"22","key":"812_CR285","doi-asserted-by":"publisher","first-page":"7851","DOI":"10.1073\/pnas.84.22.7851","volume":"84","author":"CY Wang","year":"1987","unstructured":"Wang CY, Huang L. pH-sensitive immunoliposomes mediate target-cell-specific delivery and controlled expression of a foreign gene in mouse. Proc Natl Acad Sci USA. 1987;84(22):7851\u201355. https:\/\/doi.org\/10.1073\/pnas.84.22.7851.","journal-title":"Proc Natl Acad Sci USA"},{"issue":"7","key":"812_CR286","doi-asserted-by":"publisher","first-page":"2618","DOI":"10.1073\/pnas.90.7.2618","volume":"90","author":"U Bickel","year":"1993","unstructured":"Bickel U, Yoshikawa T, Landaw EM, Faull KF, Pardridge WM. Pharmacologic effects in vivo in brain by vector-mediated peptide drug delivery. Proc Natl Acad Sci USA. 1993;90(7):2618\u201322. https:\/\/doi.org\/10.1073\/pnas.90.7.2618.","journal-title":"Proc Natl Acad Sci USA"},{"issue":"5","key":"812_CR287","doi-asserted-by":"publisher","first-page":"1327","DOI":"10.1073\/pnas.92.5.1327","volume":"92","author":"JW Park","year":"1995","unstructured":"Park JW, Hong K, Carter P, Asgari H, Guo LY, Keller GA, et al. Development of anti-p185HER2 immunoliposomes for cancer therapy. Proc Natl Acad Sci USA. 1995;92(5):1327\u201331. https:\/\/doi.org\/10.1073\/pnas.92.5.1327.","journal-title":"Proc Natl Acad Sci USA"},{"issue":"24","key":"812_CR288","doi-asserted-by":"publisher","first-page":"14164","DOI":"10.1073\/pnas.93.24.14164","volume":"93","author":"J Huwyler","year":"1996","unstructured":"Huwyler J, Wu D, Pardridge WM. Brain drug delivery of small molecules using immunoliposomes. Proc Natl Acad Sci USA. 1996;93(24):14164\u201369. https:\/\/doi.org\/10.1073\/pnas.93.24.14164.","journal-title":"Proc Natl Acad Sci USA"},{"issue":"3","key":"812_CR289","doi-asserted-by":"publisher","first-page":"1541","DOI":"10.1016\/S0022-3565(24)36946-0","volume":"282","author":"J Huwyler","year":"1997","unstructured":"Huwyler J, Yang J, Pardridge WM. Receptor mediated delivery of daunomycin using immunoliposomes: pharmacokinetics and tissue distribution in the rat. J Pharmacol Exp Ther. 1997;282(3):1541\u201346. https:\/\/doi.org\/10.1016\/S0022-3565(24)36946-0.","journal-title":"J Pharmacol Exp Ther"},{"issue":"5","key":"812_CR290","first-page":"337","volume":"1","author":"L Xu","year":"2002","unstructured":"Xu L, Huang C-C, Huang W, Tang W-H, Rait A, Yin YZ, et al. Systemic tumor-targeted gene delivery by anti-transferrin receptor scFv-immunoliposomes. Mol Cancer Ther. 2002;1(5):337\u201346.","journal-title":"Mol Cancer Ther"},{"key":"812_CR291","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.biomaterials.2016.04.034","volume":"97","author":"J Liu","year":"2016","unstructured":"Liu J, Yang Y, Zhu W, Yi X, Dong Z, Xu X, et al. Nanoscale metal\u2212organic frameworks for combined photodynamic & radiation therapy in cancer treatment. Biomaterials. 2016;97:1\u20139. https:\/\/doi.org\/10.1016\/j.biomaterials.2016.04.034.","journal-title":"Biomaterials"},{"issue":"1","key":"812_CR292","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1186\/s12987-023-00462-z","volume":"20","author":"TJ Esparza","year":"2023","unstructured":"Esparza TJ, Su S, Francescutti CM, Rodionova E, Kim JH, Brody DL. Enhanced in vivo blood brain barrier transcytosis of macromolecular cargo using an engineered pH-sensitive mouse transferrin receptor binding nanobody. Fluids Barriers CNS. 2023;20(1):64. https:\/\/doi.org\/10.1186\/s12987-023-00462-z.","journal-title":"Fluids Barriers CNS"},{"issue":"3","key":"812_CR293","doi-asserted-by":"publisher","first-page":"822","DOI":"10.1007\/s13346-022-01245-z","volume":"13","author":"B Gabold","year":"2023","unstructured":"Gabold B, Adams F, Brameyer S, Jung K, Ried CL, Merdan T, et al. Transferrin-modified chitosan nanoparticles for targeted nose-to-brain delivery of proteins. Drug Deliv. Transl. Res. 2023;13(3):822\u201338. https:\/\/doi.org\/10.1007\/s13346-022-01245-z.","journal-title":"Drug Deliv. Transl. Res"},{"key":"812_CR294","doi-asserted-by":"publisher","unstructured":"Majie A, Karmakar V, Ghosh A, Chakraborty S, A, Layek B, et al. Advanced intranasal peptide delivery systems for improved management of Alzheimer\u2019s disease. Biomater Adv. 2026;178:214474. https:\/\/doi.org\/10.1016\/j.bioadv.2025.214474.","DOI":"10.1016\/j.bioadv.2025.214474"},{"issue":"1","key":"812_CR295","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1038\/s43856-023-00419-1","volume":"4","author":"MC Lauffer","year":"2024","unstructured":"Lauffer MC, van Roon-Mom W, Aartsma-Rus A. Possibilities and limitations of antisense oligonucleotide therapies for the treatment of monogenic disorders. Commun Med. 2024;4(1):6. https:\/\/doi.org\/10.1038\/s43856-023-00419-1.","journal-title":"Commun Med"},{"issue":"2","key":"812_CR296","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1056\/NEJMoa2003715","volume":"383","author":"T Miller","year":"2020","unstructured":"Miller T, Cudkowicz M, Shaw PJ, Andersen PM, Atassi N, Bucelli RC, et al. Phase 1\u20132 trial of antisense oligonucleotide tofersen for SOD1 ALS. N Engl J Med. 2020;383(2):109\u201319. https:\/\/doi.org\/10.1056\/NEJMoa2003715.","journal-title":"N Engl J Med"},{"issue":"6","key":"812_CR297","doi-asserted-by":"publisher","first-page":"1437","DOI":"10.1038\/s41591-023-02326-3","volume":"29","author":"CJ Mummery","year":"2023","unstructured":"Mummery CJ, B\u00f6rjesson-Hanson A, Blackburn DJ, Vijverberg EGB, De Deyn PP, Ducharme S, et al. Tau-targeting antisense oligonucleotide MAPTRx in mild Alzheimer\u2019s disease: a phase 1b, randomized, placebo-controlled trial. Nat Med. 2023;29(6):1437\u201347. https:\/\/doi.org\/10.1038\/s41591-023-02326-3.","journal-title":"Nat Med"},{"issue":"8","key":"812_CR298","doi-asserted-by":"publisher","first-page":"3902","DOI":"10.1016\/j.ymthe.2025.04.046","volume":"33","author":"TC Moyer","year":"2025","unstructured":"Moyer TC, Hoffman BA, Chen W, Shah I, Ren X-Q, Knox T, et al. Highly conserved brain vascular receptor ALPL mediates transport of engineered AAV vectors across the blood-brain barrier. Mol Ther. 2025;33(8):3902\u201316. https:\/\/doi.org\/10.1016\/j.ymthe.2025.04.046.","journal-title":"Mol Ther"},{"issue":"1","key":"812_CR299","doi-asserted-by":"publisher","first-page":"3410","DOI":"10.1038\/s41467-025-58746-x","volume":"16","author":"K Tang","year":"2025","unstructured":"Tang K, Tang Z, Niu M, Kuang Z, Xue W, Wang X, et al. Allosteric targeted drug delivery for enhanced blood-brain barrier penetration via mimicking transmembrane domain interactions. Nat Commun. 2025;16(1):3410. https:\/\/doi.org\/10.1038\/s41467-025-58746-x.","journal-title":"Nat Commun"},{"issue":"4","key":"812_CR300","doi-asserted-by":"publisher","first-page":"784","DOI":"10.1210\/clinem\/dgac708","volume":"108","author":"CB Newman","year":"2023","unstructured":"Newman CB, Tobert JA. Targeting PCSK9 with antibodies and gene silencing to reduce LDL cholesterol. J CLIN ENDOCR Metab. 2023;108(4):784\u201390. https:\/\/doi.org\/10.1210\/clinem\/dgac708.","journal-title":"J CLIN ENDOCR Metab"},{"issue":"2","key":"812_CR301","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1016\/j.tibs.2006.12.008","volume":"32","author":"JD Horton","year":"2007","unstructured":"Horton JD, Cohen JC, Hobbs HH. Molecular biology of PCSK9: its role in LDL metabolism. Trends Biochemical Sci. 2007;32(2):71\u201377. https:\/\/doi.org\/10.1016\/j.tibs.2006.12.008.","journal-title":"Trends Biochemical Sci"},{"issue":"2","key":"812_CR302","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1038\/ng1509","volume":"37","author":"J Cohen","year":"2005","unstructured":"Cohen J, Pertsemlidis A, Kotowski IK, Graham R, Garcia CK, Hobbs HH. Low LDL cholesterol in individuals of African descent resulting from frequent nonsense mutations in PCSK9. Nat Genet. 2005;37(2):161\u201365. https:\/\/doi.org\/10.1038\/ng1509.","journal-title":"Nat Genet"},{"issue":"9","key":"812_CR303","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1007\/s10654-009-9386-z","volume":"24","author":"A Hofman","year":"2009","unstructured":"Hofman A, Breteler MMB, van Duijn CM, Janssen HLA, Krestin GP, Kuipers EJ, et al. The Rotterdam study: 2010 objectives and design update. Eur J Epidemiol. 2009;24(9):553\u201372. https:\/\/doi.org\/10.1007\/s10654-009-9386-z.","journal-title":"Eur J Epidemiol"},{"key":"812_CR304","doi-asserted-by":"publisher","first-page":"119310","DOI":"10.1016\/j.lfs.2021.119310","volume":"273","author":"SA Abuelezz","year":"2021","unstructured":"Abuelezz SA, Hendawy N. HMGB1\/RAGE\/TLR4 axis and glutamate as novel targets for PCSK9 inhibitor in high fat cholesterol diet induced cognitive impairment and amyloidosis. Life Sci. 2021;273:119310. https:\/\/doi.org\/10.1016\/j.lfs.2021.119310.","journal-title":"Life Sci"},{"issue":"1","key":"812_CR305","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1007\/s12035-025-05424-0","volume":"63","author":"L Zhang","year":"2026","unstructured":"Zhang L, Zhang L, Zhao J, Zhang W, Zhang H. Proprotein convertase Subtilisin\/Kexin type 9 (PCSK9) in Alzheimer\u2019s disease: recent advances and controversies. Mol Neurobiol. 2026;63(1):231. https:\/\/doi.org\/10.1007\/s12035-025-05424-0.","journal-title":"Mol Neurobiol"},{"key":"812_CR306","doi-asserted-by":"publisher","unstructured":"Robert J, Button EB, Yuen B, Gilmour M, Kang K, Bahrabadi A, et al. Clearance of beta-amyloid is facilitated by apolipoprotein E and circulating high-density lipoproteins in bioengineered human vessels. eLife. 2017;6. https:\/\/doi.org\/10.7554\/eLife.29595.","DOI":"10.7554\/eLife.29595"},{"issue":"3","key":"812_CR307","doi-asserted-by":"publisher","first-page":"928","DOI":"10.1073\/pnas.0335507100","volume":"100","author":"NG Seidah","year":"2003","unstructured":"Seidah NG, Benjannet S, Wickham L, Marcinkiewicz J, Jasmin SB, Stifani S, et al. The secretory proprotein convertase neural apoptosis-regulated convertase 1 (NARC-1): liver regeneration and neuronal differentiation. Proc Natl Acad Sci USA. 2003;100(3):928\u201333. https:\/\/doi.org\/10.1073\/pnas.0335507100.","journal-title":"Proc Natl Acad Sci USA"}],"container-title":["Fluids and Barriers of the CNS"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12987-026-00812-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12987-026-00812-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12987-026-00812-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,18]],"date-time":"2026-05-18T12:39:16Z","timestamp":1779107956000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12987-026-00812-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,16]]},"references-count":307,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["812"],"URL":"https:\/\/doi.org\/10.1186\/s12987-026-00812-7","relation":{},"ISSN":["2045-8118"],"issn-type":[{"value":"2045-8118","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,16]]},"assertion":[{"value":"21 January 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 May 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 May 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"74"}}